Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:aminobenzoic acid
go back to main search page
Accession:CHEBI:22495 term browser browse the term
Synonyms:related_synonym: Aminobenzoesaeure;   Formula=C7H7NO2


show annotations for term's descendants           Sort by:
 
3-aminobenzoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gpd1 glycerol-3-phosphate dehydrogenase 1 multiple interactions ISO [INS1 protein co-treated with 3-aminobenzoic acid] results in increased activity of GPD1 protein CTD PMID:2523799 NCBI chr 7:141,368,928...141,377,931
Ensembl chr 7:141,370,491...141,377,928
JBrowse link
4-aminobenzoic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Creb1 cAMP responsive element binding protein 1 affects expression ISO 4-Aminobenzoic Acid affects the expression of CREB1 mRNA CTD PMID:20385217 NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
JBrowse link
G Il2 interleukin 2 increases expression ISO 4-Aminobenzoic Acid results in increased expression of IL2 protein CTD PMID:22381623 NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
JBrowse link
G Nat1 N-acetyltransferase 1 multiple interactions
increases metabolic processing
affects acetylation
increases acetylation
ISO Dehydroepiandrosterone Sulfate inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Dehydroepiandrosterone Sulfate promotes the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]; Pentachlorophenol inhibits the reaction [NAT1 protein results in increased acetylation of 4-Aminobenzoic Acid]
NAT1 protein results in increased metabolism of 4-Aminobenzoic Acid
NAT1 protein affects the acetylation of 4-Aminobenzoic Acid
CTD PMID:11470991, PMID:15627487, PMID:15880531, PMID:16003948, PMID:23958860, PMID:29043425, PMID:30358977 NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
JBrowse link
G Nat2 N-acetyltransferase 2 increases acetylation
multiple interactions
ISO
EXP
NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid
4-biphenylamine inhibits the reaction [NAT2 protein results in increased acetylation of 4-Aminobenzoic Acid]
CTD PMID:15627487, PMID:18842621 NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 affects expression ISO 4-Aminobenzoic Acid affects the expression of NFKB1 mRNA CTD PMID:20385217 NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
JBrowse link
G Slc22a7 solute carrier family 22 member 7 multiple interactions ISO
EXP
4-Aminobenzoic Acid promotes the reaction [SLC22A7 protein results in increased export of Orotic Acid] CTD PMID:22981274 NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766
JBrowse link
G Tnf tumor necrosis factor affects expression ISO 4-Aminobenzoic Acid affects the expression of TNF mRNA CTD PMID:20385217 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
4-aminosalicylic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nat1 N-acetyltransferase 1 increases acetylation ISO NAT1 protein results in increased acetylation of Aminosalicylic Acid CTD PMID:15627487, PMID:16003948 NCBI chr16:23,970,742...23,991,573
Ensembl chr16:23,970,743...23,991,573
JBrowse link
G Nat2 N-acetyltransferase 2 multiple interactions ISO [Peroxynitrous Acid results in decreased activity of NAT2 protein] which results in decreased acetylation of Aminosalicylic Acid CTD PMID:19248797 NCBI chr16:23,960,709...23,991,570
Ensembl chr16:23,961,067...23,991,570
JBrowse link
anthranilic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO anthranilic acid results in increased expression of AKR1B10 mRNA CTD PMID:26198647 NCBI chr 4:61,813,265...61,830,371
Ensembl chr 4:61,771,970...61,828,657
JBrowse link
G Ifng interferon gamma multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein]; anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
JBrowse link
G Il12a interleukin 12A multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318
JBrowse link
G Il12b interleukin 12B multiple interactions ISO anthranilic acid analog inhibits the reaction [[IL12A protein binds to IL12B protein] which results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
JBrowse link
G Il18 interleukin 18 multiple interactions ISO anthranilic acid analog inhibits the reaction [IL18 protein results in increased secretion of IFNG protein] CTD PMID:15799959 NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 decreases activity ISO anthranilic acid results in decreased activity of MAP2K1 protein CTD PMID:18393446 NCBI chr 8:69,134,218...69,722,573
Ensembl chr 8:69,134,223...69,164,758
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 increases activity ISO anthranilic acid results in increased activity of NFE2L2 protein CTD PMID:30114225 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN1 protein CTD PMID:22864521 NCBI chr 3:164,665,462...164,711,936
Ensembl chr 3:164,665,532...164,711,848
JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN11 protein CTD PMID:22864521 NCBI chr12:40,895,515...40,955,999
Ensembl chr12:40,895,515...40,955,999
JBrowse link
G Ptpn2 protein tyrosine phosphatase, non-receptor type 2 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN2 protein CTD PMID:22864521 NCBI chr18:63,415,298...63,489,240
Ensembl chr18:63,415,306...63,488,027
JBrowse link
G Ptpn6 protein tyrosine phosphatase, non-receptor type 6 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN6 protein CTD PMID:22864521 NCBI chr 4:157,239,141...157,263,890
Ensembl chr 4:157,239,142...157,263,890
JBrowse link
G Ptpn9 protein tyrosine phosphatase, non-receptor type 9 multiple interactions ISO [oxovanadium IV binds to anthranilic acid analog] which results in decreased activity of PTPN9 protein CTD PMID:22864521 NCBI chr 8:61,658,851...61,739,458
Ensembl chr 8:61,659,445...61,739,434
JBrowse link
butamben term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor affects binding EXP butamben binds to AR protein CTD PMID:14565775 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Med1 mediator complex subunit 1 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to MED1 protein]; butamben promotes the reaction [NR1I2.S protein binds to MED1 protein] CTD PMID:12198127 NCBI chr10:86,101,560...86,145,271
Ensembl chr10:86,103,600...86,144,880
JBrowse link
G Ncoa1 nuclear receptor coactivator 1 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA1 protein]; butamben promotes the reaction [NR1I2.S protein binds to NCOA1 protein] CTD PMID:12198127 NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA2 protein] CTD PMID:12198127 NCBI chr 5:5,466,544...5,696,540
Ensembl chr 5:5,616,483...5,694,598
JBrowse link
G Ncoa3 nuclear receptor coactivator 3 multiple interactions ISO butamben promotes the reaction [NR1I2.L protein binds to NCOA3 protein] CTD PMID:12198127 NCBI chr 3:162,692,176...162,788,582
Ensembl chr 3:162,692,185...162,787,548
JBrowse link
Calcimycin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
ISO Calcimycin results in increased phosphorylation of AKT1 protein
Cyclosporine inhibits the reaction [Calcimycin results in increased phosphorylation of AKT1 protein]
CTD PMID:10679475 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases activity
increases expression
ISO
EXP
1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]]; 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of ALOX5 protein; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor]; bisindolylmaleimide I inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; bolinaquinone inhibits the reaction [Calcimycin results in increased activity of ALOX5 protein]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein; Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; SB 203580 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]; tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]; U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein]
Calcimycin results in increased expression of ALOX5 mRNA; Calcimycin results in increased expression of ALOX5 protein
[[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene B4; [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4; [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4]; Calcimycin results in increased activity of and results in increased localization of ALOX5 protein; Calcimycin results in increased localization of and results in increased activity of ALOX5 protein; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
CTD PMID:7665580, PMID:8387780, PMID:9445378, PMID:10779545, PMID:11529688, PMID:11698504, PMID:12604694, PMID:18083043, PMID:18218859, PMID:18475477, PMID:18475545 NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
JBrowse link
G Ano1 anoctamin 1 decreases activity ISO Calcimycin results in decreased activity of ANO1 protein CTD PMID:24478309 NCBI chr 1:217,754,349...217,902,540
Ensembl chr 1:217,754,336...217,902,473
JBrowse link
G Apoe apolipoprotein E decreases response to substance ISO APOE gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:11397713 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
ISO Calcimycin affects the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in decreased expression of BAX mRNA]
Calcimycin results in increased expression of BAX mRNA
CTD PMID:26419736 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
JBrowse link
G Bcl2l1 Bcl2-like 1 decreases response to substance EXP BCL2L1 gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:10970895 NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP2 mRNA] CTD PMID:21331654 NCBI chr 3:126,335,963...126,346,771
Ensembl chr 3:126,335,863...126,346,318
JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of BMP6 mRNA] CTD PMID:21331654 NCBI chr17:26,955,142...27,112,820
Ensembl chr17:26,955,142...27,112,820
JBrowse link
G Casp1 caspase 1 multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased cleavage of CASP1 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased activity of CASP1 protein] CTD PMID:21515303, PMID:22322153, PMID:23535185 NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
JBrowse link
G Casp3 caspase 3 increases expression
multiple interactions
EXP
ISO
Calcimycin results in increased expression of CASP3 protein
Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in increased activity of CASP3 protein]
CTD PMID:16787641, PMID:19837105, PMID:20020783 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casp7 caspase 7 increases activity ISO Calcimycin results in increased activity of CASP7 protein CTD PMID:19139269 NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
JBrowse link
G Casp8 caspase 8 increases activity ISO Calcimycin results in increased activity of CASP8 protein CTD PMID:25410152 NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
JBrowse link
G Casp9 caspase 9 increases activity ISO Calcimycin results in increased activity of CASP9 protein CTD PMID:25410152 NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA; CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL11 mRNA]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]] CTD PMID:12797483, PMID:21331654 NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
ISO Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of CCL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CCL2 mRNA
Calcimycin results in increased expression of CCL2 mRNA
CTD PMID:8764118, PMID:18799549, PMID:30254419 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression
multiple interactions
ISO Calcimycin results in increased expression of CCL4 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of CCL4 mRNA]
CTD PMID:25451590 NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO
EXP
CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]
[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA]; CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein]; Dexamethasone inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]; Masoprocol inhibits the reaction [[Calcimycin co-treated with CCL5 protein] results in increased secretion of Leukotriene B4]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA]; Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein]
CTD PMID:12797483, PMID:18083043 NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression
multiple interactions
ISO Calcimycin results in increased expression of CCL7 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA]
CTD PMID:25451590 NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
JBrowse link
G Cd40 CD40 molecule multiple interactions ISO Apigenin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein]; Luteolin inhibits the reaction [Calcimycin results in increased expression of CD40 protein]; Quercetin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CD40 protein] CTD PMID:16601352 NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
JBrowse link
G Cd69 Cd69 molecule multiple interactions
increases expression
ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CD69 protein]
Calcimycin results in increased expression of CD69 protein
CTD PMID:23941771, PMID:25410152 NCBI chr 4:163,041,147...163,049,065
Ensembl chr 4:163,041,141...163,049,084
JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO Calcimycin promotes the reaction [Cadmium Chloride results in increased cleavage of CDH1 protein] CTD PMID:18791180 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395
JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
increases secretion
increases expression
ISO
EXP
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
Calcimycin results in increased secretion of CSF2 protein
Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA]
CTD PMID:1376361, PMID:9685678, PMID:17950587 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression
multiple interactions
ISO Calcimycin results in increased expression of AXUD1 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]
CTD PMID:25451590 NCBI chr 8:128,659,883...128,673,339
Ensembl chr 8:128,659,868...128,672,284
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO Calcimycin results in increased expression of CXCL1 mRNA CTD PMID:8764118 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases activity
increases expression
multiple interactions
ISO Calcimycin results in increased activity of DDIT3 protein
Calcimycin results in increased expression of DDIT3 mRNA; Calcimycin results in increased expression of DDIT3 protein
parthenolide promotes the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]
CTD PMID:11145585, PMID:11360202, PMID:19139269, PMID:19428936, PMID:27064126 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression
multiple interactions
ISO Calcimycin results in increased expression of DUSP1 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP1 mRNA]
CTD PMID:25451590 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression
multiple interactions
ISO Calcimycin results in increased expression of DUSP6 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP6 mRNA]
CTD PMID:25451590 NCBI chr 7:41,475,163...41,479,393
Ensembl chr 7:41,475,163...41,479,392
JBrowse link
G Edn1 endothelin 1 multiple interactions EXP [EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]; Polyphenols inhibits the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides] CTD PMID:20977430 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
JBrowse link
G Egr1 early growth response 1 increases expression ISO Calcimycin results in increased expression of EGR1 mRNA CTD PMID:8764118 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
JBrowse link
G Egr2 early growth response 2 increases expression
multiple interactions
ISO Calcimycin results in increased expression of EGR2 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA]
CTD PMID:25451590 NCBI chr20:22,452,170...22,461,018
Ensembl chr20:22,454,463...22,459,025
JBrowse link
G Egr3 early growth response 3 increases expression
multiple interactions
ISO Calcimycin results in increased expression of EGR3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA]
CTD PMID:25451590 NCBI chr15:51,756,683...51,762,080
Ensembl chr15:51,756,736...51,760,722
JBrowse link
G Eif2a eukaryotic translation initiation factor 2A increases phosphorylation
multiple interactions
ISO Calcimycin results in increased phosphorylation of EIF2A protein
Quercetin inhibits the reaction [Calcimycin results in increased phosphorylation of EIF2A protein]
CTD PMID:19428936 NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases expression ISO Calcimycin results in increased expression of ERN1 protein CTD PMID:19139269 NCBI chr10:94,588,555...94,682,072
Ensembl chr10:94,588,555...94,681,914
JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FAS mRNA] CTD PMID:21331654 NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
JBrowse link
G Faslg Fas ligand affects expression ISO Calcimycin affects the expression of FASL protein
Calcimycin affects the expression of FASLG protein
CTD PMID:25410152 NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression EXP Calcimycin results in increased expression of FGF1 protein CTD PMID:15264218 NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of FLT3 mRNA] CTD PMID:21331654 NCBI chr12:9,360,439...9,437,004
Ensembl chr12:9,360,672...9,436,570
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
EXP
ISO
Luteolin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of FOS mRNA]
CTD PMID:1932749, PMID:8764118, PMID:17950587, PMID:25451590 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
ISO Calcimycin results in increased expression of FOSB mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of FOSB mRNA]
CTD PMID:8764118, PMID:25451590 NCBI chr 1:80,214,691...80,221,417
Ensembl chr 1:80,214,494...80,221,710
JBrowse link
G Gbp3 guanylate binding protein 3 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of GBP3 mRNA] CTD PMID:21331654 NCBI chr 2:248,450,908...248,491,258
Ensembl chr 2:248,451,547...248,484,100
JBrowse link
G Gch1 GTP cyclohydrolase 1 multiple interactions EXP [2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin; sepiapterin inhibits the reaction [[2,4-diaminohypoxanthine results in decreased activity of GCH1 protein] which affects the susceptibility to Calcimycin] CTD PMID:12855421 NCBI chr15:23,935,011...23,968,971
Ensembl chr15:23,934,585...23,969,011
JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression ISO Calcimycin results in decreased expression of GPX4 protein CTD PMID:10432307 NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
JBrowse link
G Hdc histidine decarboxylase increases expression
multiple interactions
ISO Calcimycin results in increased expression of HDC mRNA
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein; atractylon inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]; pyeongwee-san extract inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased activity of HDC protein]
CTD PMID:17191106, PMID:27553716 NCBI chr 3:119,057,524...119,075,599
Ensembl chr 3:119,057,517...119,075,619
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]] CTD PMID:12788823 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
JBrowse link
G Hsf1 heat shock transcription factor 1 affects phosphorylation ISO Calcimycin affects the phosphorylation of HSF1 protein CTD PMID:8663271 NCBI chr 7:117,538,523...117,565,478
Ensembl chr 7:117,538,523...117,565,478
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions
increases expression
ISO Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 mRNA]; Quercetin inhibits the reaction [Calcimycin results in increased expression of HSPA5 protein]
Calcimycin results in increased expression of HSPA5 mRNA; Calcimycin results in increased expression of HSPA5 protein
CTD PMID:12147617, PMID:14610226, PMID:18799549, PMID:19139269, PMID:19428936, PMID:27064126 NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
JBrowse link
G Ifng interferon gamma multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein] CTD PMID:1371491, PMID:14994387 NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
JBrowse link
G Il12rb1 interleukin 12 receptor subunit beta 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL12RB1 mRNA] CTD PMID:21331654 NCBI chr16:20,370,722...20,383,576
Ensembl chr16:20,371,338...20,383,337
JBrowse link
G Il13 interleukin 13 multiple interactions
increases expression
ISO
EXP
[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL13 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13 mRNA]
shikonin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA]
CTD PMID:12789233, PMID:17950587, PMID:21331654, PMID:25451590 NCBI chr10:38,982,909...38,985,466
Ensembl chr10:38,982,909...38,985,466
JBrowse link
G Il13ra1 interleukin 13 receptor subunit alpha 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL13RA1 mRNA] CTD PMID:21331654 NCBI chr  X:122,724,081...122,783,801
Ensembl chr  X:122,724,129...122,781,479
JBrowse link
G Il18r1 interleukin 18 receptor 1 multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL18R1 protein CTD PMID:14994387 NCBI chr 9:47,184,404...47,217,403
Ensembl chr 9:47,185,443...47,219,175
JBrowse link
G Il1a interleukin 1 alpha increases expression ISO Calcimycin results in increased expression of IL1A mRNA CTD PMID:8435107 NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA; [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL1B protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL1B protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL1B mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]] CTD PMID:15705740, PMID:17588137, PMID:18958421, PMID:21515303, PMID:22322153, PMID:23535185, PMID:24131540, PMID:30254419 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein] CTD PMID:1371491, PMID:23941771 NCBI chr 2:123,847,150...123,851,854
Ensembl chr 2:123,847,150...123,851,854
JBrowse link
G Il3 interleukin 3 multiple interactions
increases expression
ISO
EXP
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]; Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL3 mRNA]
CTD PMID:1376361, PMID:17950587 NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
JBrowse link
G Il4 interleukin 4 multiple interactions
increases expression
affects response to substance
ISO
EXP
[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL4 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; IL4 protein inhibits the reaction [Calcimycin results in increased metabolism of Leukotriene B4]; IL4 protein promotes the reaction [Calcimycin results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Luteolin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4]; plant extract, Houttuynia cordata inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]
Luteolin inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of IL4 mRNA]
IL4 protein affects the susceptibility to Calcimycin
CTD PMID:1371491, PMID:11861792, PMID:12789233, PMID:16601352, PMID:17950587, PMID:18325701, PMID:21515303 NCBI chr10:38,963,979...38,969,531
Ensembl chr10:38,963,979...38,969,531
JBrowse link
G Il5 interleukin 5 multiple interactions
increases expression
ISO [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; fisetin inhibits the reaction [[Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL5 protein]; fisetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; IL5 protein promotes the reaction [CCL11 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; IL5 protein promotes the reaction [CCL5 protein promotes the reaction [Calcimycin affects the abundance of and affects the chemical synthesis of Reactive Oxygen Species]]; kaempferol inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; plant extract, Houttuynia cordata inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]; Quercetin inhibits the reaction [Calcimycin results in increased expression of IL5 mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein] CTD PMID:1371491, PMID:12789233, PMID:12797483, PMID:18325701 NCBI chr10:39,066,716...39,069,587
Ensembl chr10:39,066,716...39,069,587
JBrowse link
G Il6 interleukin 6 multiple interactions
increases secretion
increases expression
ISO 3'(R)-O-beta-D-glucopyranosyl-3',4'-dihydroxanthyletin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; [Calcimycin co-treated with phorbol-12-myristate] results in increased expression of IL6 protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein; Calcimycin inhibits the reaction [Calcium promotes the reaction [Histamine results in increased expression of IL6 protein]]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; levistolide A inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of IL6 protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of IL6 protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL6 mRNA]
Calcimycin results in increased secretion of IL6 protein
Calcimycin results in increased expression of IL6 mRNA
CTD PMID:11238657, PMID:12789233, PMID:17191106, PMID:17588137, PMID:18958421, PMID:19118619, PMID:19416633, PMID:19665545, PMID:21515303, PMID:22322153, PMID:23535185, PMID:24131540, PMID:30254419, PMID:30496664 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Inhbc inhibin subunit beta C multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of INHBC mRNA] CTD PMID:21331654 NCBI chr 7:70,648,005...70,661,475
Ensembl chr 7:70,646,519...70,661,891
JBrowse link
G Irf8 interferon regulatory factor 8 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IRF8 mRNA] CTD PMID:21331654 NCBI chr19:54,314,859...54,336,643
Ensembl chr19:54,314,865...54,336,640
JBrowse link
G Itga2 integrin subunit alpha 2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGA2 mRNA] CTD PMID:21331654 NCBI chr 2:46,996,904...47,097,011
Ensembl chr 2:47,000,323...47,096,961
JBrowse link
G Itgam integrin subunit alpha M increases expression
multiple interactions
ISO Calcimycin results in increased expression of ITGAM protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA; Dexamethasone analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of ITGAM mRNA]; Resveratrol analog inhibits the reaction [Calcimycin results in increased expression of ITGAM protein]
CTD PMID:8094364, PMID:18776917, PMID:21331654 NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
JBrowse link
G Itgb2 integrin subunit beta 2 increases expression ISO Calcimycin results in increased expression of ITGB2 protein CTD PMID:8094364 NCBI chr20:11,777,773...11,815,647
Ensembl chr20:11,777,783...11,815,647
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
ISO Calcimycin results in increased expression of JUN mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of JUN mRNA]
CTD PMID:8764118, PMID:25451590 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression
ISO 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin analog results in increased expression of JUNB mRNA]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [Calcimycin results in increased expression of JUNB mRNA] CTD PMID:1932749, PMID:8764118 NCBI chr19:26,092,972...26,094,756
Ensembl chr19:26,092,974...26,094,756
JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 decreases expression ISO Calcimycin results in decreased expression of KCNJ5 mRNA CTD PMID:22798349 NCBI chr 8:33,435,493...33,463,410
Ensembl chr 8:33,433,905...33,463,467
JBrowse link
G Kcnn4 potassium calcium-activated channel subfamily N member 4 increases activity ISO Calcimycin results in increased activity of KCNN4 protein CTD PMID:17699636 NCBI chr 1:81,227,855...81,245,986
Ensembl chr 1:81,230,612...81,245,996
JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 increases expression
multiple interactions
ISO Calcimycin results in increased expression of MAP3K8 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA]
CTD PMID:25451590 NCBI chr17:56,109,403...56,129,925
Ensembl chr17:56,109,549...56,129,919
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK1 protein]
Calcimycin results in increased phosphorylation of MAPK1 protein
CTD PMID:18776917, PMID:19416633, PMID:19782052 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein; Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein; resveratrol analog inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of MAPK3 protein]
Calcimycin results in increased phosphorylation of MAPK3 protein
CTD PMID:18776917, PMID:19416633, PMID:19782052 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MAPK8 mRNA] CTD PMID:21331654 NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
JBrowse link
G Mpo myeloperoxidase increases secretion
multiple interactions
affects activity
ISO
EXP
Calcimycin results in increased secretion of MPO protein
carvedilol inhibits the reaction [Calcimycin results in increased secretion of MPO protein]
Calcimycin affects the activity of MPO protein
CTD PMID:18475545, PMID:18987595 NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
JBrowse link
G Ms4a2 membrane spanning 4-domains A2 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of MS4A2 mRNA] CTD PMID:21331654 NCBI chr 1:227,957,363...227,965,312
Ensembl chr 1:227,957,302...227,965,386
JBrowse link
G Msr1 macrophage scavenger receptor 1 multiple interactions ISO Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of MSR1 mRNA alternative form] CTD PMID:10837497 NCBI chr16:56,817,714...56,900,025
Ensembl chr16:56,813,791...56,900,052
JBrowse link
G Mt1 metallothionein 1 increases expression EXP Calcimycin results in increased expression of MT1A mRNA CTD PMID:8128501 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
JBrowse link
G Mt2A metallothionein 2A multiple interactions
increases expression
ISO shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] CTD PMID:25451590 NCBI chr19:11,307,966...11,308,740
Ensembl chr19:11,307,967...11,308,740
JBrowse link
G Naga alpha-N-acetylgalactosaminidase affects activity EXP Calcimycin affects the activity of NAGA protein CTD PMID:18475545 NCBI chr 7:123,563,047...123,572,074
Ensembl chr 7:123,563,059...123,572,082
JBrowse link
G Nfatc1 nuclear factor of activated T-cells 1 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of NFATC1 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in decreased expression of NFATC1 protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of NFATC1 protein; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612, PMID:24244623 NCBI chr18:77,203,517...77,322,690
Ensembl chr18:77,203,525...77,322,690
JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 increases activity
multiple interactions
ISO Calcimycin results in increased activity of NFATC2 protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein; Cyclosporine inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; fisetin inhibits the reaction [Calcimycin results in increased activity of NFATC2 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased phosphorylation of NFATC2 protein]
CTD PMID:12789233, PMID:21603612, PMID:23941771 NCBI chr 3:165,241,750...165,374,644
Ensembl chr 3:165,245,238...165,360,292
JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr19:38,039,542...38,114,003
Ensembl chr19:38,039,564...38,114,003
JBrowse link
G Nfatc4 nuclear factor of activated T-cells 4 multiple interactions ISO NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr15:34,493,163...34,502,238
Ensembl chr15:34,493,138...34,504,326
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased degradation of NFKBIA protein] CTD PMID:17588137, PMID:19416633, PMID:19665545, PMID:21515303, PMID:22322153, PMID:23535185, PMID:23941771 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
JBrowse link
G Nfkbid NFKB inhibitor delta increases expression
multiple interactions
ISO Calcimycin results in increased expression of NFKBID mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBID mRNA]
CTD PMID:25451590 NCBI chr 1:88,883,816...88,892,543
Ensembl chr 1:88,885,937...88,892,615
JBrowse link
G Nfkbiz NFKB inhibitor zeta increases expression
multiple interactions
ISO Calcimycin results in increased expression of NFKBIZ mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBIZ mRNA]
CTD PMID:25451590 NCBI chr11:47,243,342...47,271,487
Ensembl chr11:47,243,342...47,271,487
JBrowse link
G Ngf nerve growth factor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] inhibits the reaction [Cyclosporine results in increased expression of NGF protein]; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in decreased expression of NGF protein CTD PMID:24244623 NCBI chr 2:204,886,158...204,939,523
Ensembl chr 2:204,886,202...204,940,453
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO NOS2 protein affects the susceptibility to [Phenylephrine co-treated with Calcimycin] CTD PMID:11498454 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Nos3 nitric oxide synthase 3 increases activity
increases expression
multiple interactions
EXP
ISO
Calcimycin results in increased activity of NOS3 protein
Calcimycin results in increased expression of NOS3 mRNA
Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]
[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides; Nitroglycerin promotes the reaction [[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides]; NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides]
CTD PMID:10625313, PMID:11796706, PMID:19837105, PMID:20020783, PMID:20977430 NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 multiple interactions
increases expression
ISO NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] CTD PMID:25451590 NCBI chr 7:142,899,358...142,920,216
Ensembl chr 7:142,905,758...142,920,216
JBrowse link
G Nr4a2 nuclear receptor subfamily 4, group A, member 2 increases expression
multiple interactions
ISO Calcimycin results in increased expression of NR4A2 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA]
CTD PMID:25451590 NCBI chr 3:43,111,258...43,128,391
Ensembl chr 3:43,111,240...43,119,159
JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 increases expression
multiple interactions
ISO Calcimycin results in increased expression of NR4A3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA]
CTD PMID:25451590 NCBI chr 5:63,781,801...63,822,890
Ensembl chr 5:63,781,801...63,821,637
JBrowse link
G Ntf3 neurotrophin 3 increases expression EXP Calcimycin results in increased expression of NTF3 protein CTD PMID:19854260 NCBI chr 4:158,636,883...158,705,886
Ensembl chr 4:158,636,884...158,705,886
JBrowse link
G Otc ornithine carbamoyltransferase multiple interactions EXP [Calcimycin co-treated with Cyclosporine] results in decreased activity of OTC protein; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein]] CTD PMID:3097147 NCBI chr  X:13,524,804...13,601,074
Ensembl chr  X:13,524,607...13,601,069
JBrowse link
G Padi4 peptidyl arginine deiminase 4 multiple interactions ISO Calcimycin inhibits the reaction [Dimethyl Sulfoxide results in increased expression of PADI4 protein] CTD PMID:29425503 NCBI chr 5:159,260,675...159,293,906
Ensembl chr 5:159,260,675...159,293,673
JBrowse link
G Plk3 polo-like kinase 3 increases expression
multiple interactions
ISO Calcimycin results in increased expression of PLK3 mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of PLK3 mRNA]
CTD PMID:25451590 NCBI chr 5:135,997,725...136,002,900
Ensembl chr 5:135,997,725...136,002,900
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression
multiple interactions
ISO Calcimycin results in increased expression of PPP1R15A mRNA
shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA]
CTD PMID:25451590 NCBI chr 1:101,511,899...101,515,043
Ensembl chr 1:101,511,901...101,514,974
JBrowse link
G Prkaa1 protein kinase AMP-activated catalytic subunit alpha 1 increases phosphorylation ISO Calcimycin results in increased phosphorylation of PRKAA1 protein CTD PMID:28298333 NCBI chr 2:54,857,688...54,893,404
Ensembl chr 2:54,857,688...54,893,404
JBrowse link
G Prkcd protein kinase C, delta multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein; Oils, Volatile inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein]; Plant Oils inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased phosphorylation of PRKCD protein] CTD PMID:23941771 NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
JBrowse link
G Prl prolactin multiple interactions EXP [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]; Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]; Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; Cyclosporine inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein]]; didemnins inhibits the reaction [Calcimycin promotes the reaction [PRL protein results in increased activity of OTC protein]] CTD PMID:3097147 NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO [IL1B protein co-treated with Calcimycin] results in increased activity of PTGS2 protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein; Calcimycin promotes the reaction [[Hydrogen Peroxide co-treated with Vanadates] results in increased expression of PTGS2 mRNA alternative form]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 mRNA]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of PTGS2 protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]
Calcimycin results in increased expression of PTGS2 mRNA; Calcimycin results in increased expression of PTGS2 protein
shikonin inhibits the reaction [Calcimycin results in increased expression of PTGS2 mRNA]
CTD PMID:9013627, PMID:10837497, PMID:15705740, PMID:19416633, PMID:19782052, PMID:25451590 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Ptprc protein tyrosine phosphatase, receptor type, C affects response to substance
increases response to substance
increases expression
ISO PTPRC protein affects the susceptibility to Calcimycin
PTPRC protein results in increased susceptibility to Calcimycin
Calcimycin results in increased expression of PTPRC protein
CTD PMID:25410152 NCBI chr13:55,061,561...55,174,150
Ensembl chr13:55,061,562...55,173,692
JBrowse link
G Pygl glycogen phosphorylase L increases activity
multiple interactions
EXP Calcimycin results in increased activity of PYGL protein
Calcium deficiency inhibits the reaction [Calcimycin results in increased activity of PYGL protein]
CTD PMID:6430282 NCBI chr 6:92,597,759...92,643,734
Ensembl chr 6:92,597,706...92,643,847
JBrowse link
G Rcan1 regulator of calcineurin 1 increases expression ISO Calcimycin results in increased expression of RCAN1 protein CTD PMID:12927602 NCBI chr11:32,539,689...32,620,274
Ensembl chr11:32,539,683...32,550,539
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases response to substance
multiple interactions
ISO RELA gene mutant form results in increased susceptibility to Calcimycin
[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of and results in increased activity of RELA protein]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]; RELA protein inhibits the reaction [Calcimycin results in increased expression of DDIT3 mRNA]; resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of RELA protein]
CTD PMID:11360202, PMID:17588137, PMID:18958421, PMID:19416633, PMID:19665545, PMID:21515303, PMID:22322153, PMID:23535185 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
JBrowse link
G Sell selectin L decreases expression
multiple interactions
ISO Calcimycin results in decreased expression of SELL protein
[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA; fulvic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of SELL mRNA]; resveratrol analog inhibits the reaction [Calcimycin results in decreased expression of SELL protein]
CTD PMID:18776917, PMID:21331654 NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
JBrowse link
G Selp selectin P increases expression ISO Calcimycin results in increased expression of SELP protein CTD PMID:24466103 NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
JBrowse link
G Sirt1 sirtuin 1 affects response to substance EXP SIRT1 protein affects the susceptibility to Calcimycin CTD PMID:23422569 NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
JBrowse link
G Sp1 Sp1 transcription factor multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of SP1 protein CTD PMID:24244623 NCBI chr 7:144,014,173...144,044,635
Ensembl chr 7:144,014,173...144,044,629
JBrowse link
G Sptan1 spectrin, alpha, non-erythrocytic 1 increases cleavage
multiple interactions
ISO Calcimycin results in increased cleavage of SPTAN1 protein
rosiglitazone inhibits the reaction [Calcimycin results in increased cleavage of SPTAN1 protein]
CTD PMID:19226370 NCBI chr 3:8,534,437...8,599,259
Ensembl chr 3:8,534,440...8,599,260
JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase increases phosphorylation ISO Calcimycin results in increased phosphorylation of SRC protein CTD PMID:19782052 NCBI chr 3:153,547,807...153,595,643
Ensembl chr 3:153,580,861...153,595,642
JBrowse link
G Tagap T-cell activation RhoGTPase activating protein multiple interactions
increases expression
ISO shikonin inhibits the reaction [Calcimycin results in increased expression of TAGAP mRNA] CTD PMID:25451590 NCBI chr 1:47,493,990...47,503,492
Ensembl chr 1:47,493,994...47,502,952
JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]; Sphingosine inhibits the reaction [Calcimycin promotes the reaction [Dexamethasone results in increased activity of TAT protein]] CTD PMID:9398635 NCBI chr19:41,675,639...41,686,195
Ensembl chr19:41,675,355...41,686,229
JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression ISO Calcimycin results in increased expression of TGFB1 mRNA CTD PMID:8148055 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
ISO
EXP
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA; [Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein; Calcimycin results in increased expression of and results in increased secretion of TNF protein; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Doxycycline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; fisetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; fraxetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; galangin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; geraniol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; isopraeroside IV inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; myricetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of and results in increased expression of TNF protein]; Plant Extracts inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; prolinedithiocarbamate inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; pyrazolanthrone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of and results in increased secretion of TNF protein]; Resveratrol inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]; SB 203580 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF mRNA]; tetracycline CMT-3 inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased secretion of TNF protein]
Calcimycin results in increased expression of TNF mRNA
Luteolin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]; thunberginol B inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]
Calcimycin inhibits the reaction [TNF protein results in increased expression of CCL2 protein]; NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA]
CTD PMID:1371491, PMID:16134060, PMID:17588137, PMID:17950587, PMID:18799549, PMID:18958421, PMID:19118619, PMID:19416633, PMID:19665545, PMID:21515303, PMID:22322153, PMID:23426871, PMID:23535185, PMID:24131540, PMID:25451590, PMID:30254419, PMID:30496664 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein; Cyclosporine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC1 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC2 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC3 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein]; NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
JBrowse link
G Tp53 tumor protein p53 multiple interactions
increases expression
ISO [[Air Pollutants results in increased abundance of Particulate Matter] which co-treated with Calcimycin] affects the expression of TP53 mRNA
Calcimycin results in increased expression of TP53 mRNA
CTD PMID:26419736 NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
JBrowse link
G Tslp thymic stromal lymphopoietin multiple interactions ISO [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA; [Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein; Dexamethasone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; naringin inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP mRNA]; Plant Preparations inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TSLP protein] CTD PMID:24131540 NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361
JBrowse link
G Uhrf1 ubiquitin-like with PHD and ring finger domains 1 decreases expression ISO Calcimycin results in decreased expression of UHRF1 mRNA; Calcimycin results in decreased expression of UHRF1 protein CTD PMID:15964557 NCBI chr 9:10,738,211...10,758,403
Ensembl chr 9:10,738,222...10,757,954
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions
increases secretion
increases expression
ISO Calcimycin inhibits the reaction [1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [VEGFA protein results in increased expression of HMOX1 protein]]
Calcimycin results in increased secretion of VEGFA protein
Calcimycin results in increased expression of VEGFA mRNA
CTD PMID:9743532, PMID:12147617, PMID:12788823 NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
JBrowse link
G Xbp1 X-box binding protein 1 increases splicing
multiple interactions
ISO Calcimycin results in increased splicing of XBP1 mRNA
Quercetin inhibits the reaction [Calcimycin results in increased splicing of XBP1 mRNA]
CTD PMID:19428936 NCBI chr14:85,753,736...85,758,820
Ensembl chr14:85,753,760...85,758,145
JBrowse link
G Zfp36 zinc finger protein 36 multiple interactions
increases expression
ISO shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA] CTD PMID:25451590 NCBI chr 1:85,380,088...85,382,565
Ensembl chr 1:85,380,088...85,382,569
JBrowse link
fenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adam17 ADAM metallopeptidase domain 17 increases response to substance ISO ADAM17 results in increased susceptibility to fenamic acid CTD PMID:12147693 NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 decreases activity ISO fenamic acid analog results in decreased activity of AKR1C2 protein CTD PMID:19010312 NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO fenamic acid analog results in decreased activity of AKR1C3 protein CTD PMID:19010312 NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions ISO fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] CTD PMID:12542607 NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions
decreases activity
ISO
EXP
fenamic acid inhibits the reaction [[[Colforsin co-treated with Genistein] results in increased activity of CFTR protein] which results in increased transport of Iodides]; fenamic acid inhibits the reaction [Colforsin results in increased activity of CFTR protein]
fenamic acid results in decreased activity of CFTR protein
CTD PMID:14502435, PMID:14668136, PMID:15020588, PMID:15277574, PMID:15857825, PMID:15921678, PMID:15986093, PMID:16038730, PMID:18230692 NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP fenamic acid results in increased expression of HAVCR1 mRNA CTD PMID:23142791 NCBI chr10:31,813,819...31,860,934
Ensembl chr10:31,813,814...31,848,379
JBrowse link
G Krt14 keratin 14 increases expression EXP fenamic acid results in increased expression of KRT14 mRNA CTD PMID:23142791 NCBI chr10:88,118,029...88,122,233
Ensembl chr10:88,055,823...88,122,233
JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 increases expression EXP fenamic acid results in increased expression of LMCD1 mRNA CTD PMID:23558518 NCBI chr 4:144,192,989...144,252,554
Ensembl chr 4:144,192,989...144,252,551
JBrowse link
G Mir210 microRNA 210 affects expression EXP fenamic acid affects the expression of MIR210 CTD PMID:30169741 NCBI chr 1:214,208,355...214,208,464 JBrowse link
G Tgfb2 transforming growth factor, beta 2 increases expression EXP fenamic acid results in increased expression of TGFB2 mRNA CTD PMID:23558518 NCBI chr13:105,039,639...105,142,010
Ensembl chr13:105,039,853...105,141,030
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO fenamic acid inhibits the reaction [TNF protein results in increased transport of Chlorides] CTD PMID:10783394 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Vip vasoactive intestinal peptide multiple interactions ISO fenamic acid promotes the reaction [VIP protein results in increased expression of AQP3 mRNA] CTD PMID:12542607 NCBI chr 1:42,169,307...42,177,582
Ensembl chr 1:42,169,501...42,177,582
JBrowse link
flufenamic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adam17 ADAM metallopeptidase domain 17 increases response to substance ISO ADAM17 results in increased susceptibility to Flufenamic Acid CTD PMID:12147693 NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases activity
multiple interactions
ISO Flufenamic Acid results in decreased activity of AKR1C4 protein
Flufenamic Acid inhibits the reaction [AKR1C4 protein results in increased metabolism of Dihydrotestosterone]
CTD PMID:12604236, PMID:14672942 NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 multiple interactions
decreases activity
ISO Flufenamic Acid inhibits the reaction [AKR1C2 protein results in increased metabolism of Dihydrotestosterone]
Flufenamic Acid results in decreased activity of AKR1C2 protein
CTD PMID:8573067, PMID:12604236, PMID:14672942 NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 affects binding
multiple interactions
decreases activity
ISO Flufenamic Acid binds to AKR1C3 protein
Flufenamic Acid inhibits the reaction [AKR1C3 protein affects the susceptibility to oxaliplatin]; Flufenamic Acid inhibits the reaction [AKR1C3 protein results in increased metabolism of Dihydrotestosterone]
Flufenamic Acid results in decreased activity of AKR1C3 protein
CTD PMID:12604236, PMID:14672942, PMID:14996743, PMID:23933386 NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
JBrowse link
G Ar androgen receptor multiple interactions
decreases expression
ISO Flufenamic Acid analog binds to and results in decreased activity of AR protein; Flufenamic Acid binds to and results in decreased activity of AR protein
Flufenamic Acid results in decreased expression of AR mRNA; Flufenamic Acid results in decreased expression of AR protein
CTD PMID:10537180, PMID:19645433 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026
JBrowse link
G Asic5 acid sensing ion channel subunit family member 5 multiple interactions ISO Flufenamic Acid binds to and results in increased activity of ASIC5 protein CTD PMID:21828194 NCBI chr 2:180,935,392...180,964,365
Ensembl chr 2:180,936,688...180,964,365
JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAD protein] CTD PMID:27957685 NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAK1 protein] CTD PMID:27957685 NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
JBrowse link
G Best1 bestrophin 1 decreases activity ISO Flufenamic Acid results in decreased activity of BEST1 protein CTD PMID:19828819 NCBI chr 1:226,033,146...226,049,893
Ensembl chr 1:226,030,875...226,049,929
JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BID protein] CTD PMID:27957685 NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
JBrowse link
G Casp3 caspase 3 multiple interactions ISO Flufenamic Acid inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP3 protein modified form] CTD PMID:27957685 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
JBrowse link
G Casr calcium-sensing receptor multiple interactions ISO Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium] CTD PMID:21562303 NCBI chr11:67,188,204...67,262,261
Ensembl chr11:67,188,630...67,258,771
JBrowse link
G Cftr CF transmembrane conductance regulator decreases activity ISO Flufenamic Acid results in decreased activity of CFTR protein CTD PMID:15277574 NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
JBrowse link
G Cga glycoprotein hormones, alpha polypeptide multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of CGA mRNA CTD PMID:8404651 NCBI chr 5:50,362,491...50,393,368
Ensembl chr 5:50,381,244...50,393,367
JBrowse link
G Chrm1 cholinergic receptor, muscarinic 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium] CTD PMID:18316702 NCBI chr 1:224,869,087...224,885,101
Ensembl chr 1:224,882,439...224,884,205
JBrowse link
G Dhrs11 dehydrogenase/reductase 11 decreases activity ISO Flufenamic Acid results in decreased activity of DHRS11 protein CTD PMID:30926317 NCBI chr10:72,144,042...72,153,496
Ensembl chr10:72,144,042...72,153,375
JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of FSHB mRNA CTD PMID:8404651 NCBI chr 3:98,088,321...98,092,131
Ensembl chr 3:98,088,324...98,092,131
JBrowse link
G Grm1 glutamate metabotropic receptor 1 multiple interactions EXP Flufenamic Acid inhibits the reaction [3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein]; Flufenamic Acid inhibits the reaction [[3,5-dihydroxyphenylglycine results in increased activity of GRM1 protein] which results in increased abundance of Calcium] CTD PMID:14622174 NCBI chr 1:4,753,141...5,165,859
Ensembl chr 1:4,753,144...5,165,859
JBrowse link
G Gstp1 glutathione S-transferase pi 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] CTD PMID:23769903 NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein] CTD PMID:10866999 NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
JBrowse link
G Il6 interleukin 6 increases expression
multiple interactions
EXP
ISO
Flufenamic Acid results in increased expression of IL6 mRNA
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD PMID:15135310, PMID:24849676 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 multiple interactions ISO E 4031 inhibits the reaction [Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium]]; Flufenamic Acid promotes the reaction [KCNH2 protein results in increased transport of Potassium] CTD PMID:12359267 NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
JBrowse link
G Kcnk10 potassium two pore domain channel subfamily K member 10 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK10 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr 6:122,417,079...122,549,532
Ensembl chr 6:122,419,046...122,545,899
JBrowse link
G Kcnk2 potassium two pore domain channel subfamily K member 2 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK2 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr13:107,690,111...107,886,476
Ensembl chr13:107,690,087...107,886,476
JBrowse link
G Kcnk4 potassium two pore domain channel subfamily K member 4 multiple interactions ISO Flufenamic Acid promotes the reaction [KCNK4 protein results in increased transport of Potassium] CTD PMID:16075240 NCBI chr 1:222,182,997...222,192,139
Ensembl chr 1:222,183,276...222,189,604
JBrowse link
G Kiss1 KiSS-1 metastasis-suppressor multiple interactions ISO Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] CTD PMID:18948403 NCBI chr13:50,529,506...50,537,603
Ensembl chr13:50,529,510...50,535,389
JBrowse link
G Kiss1r KISS1 receptor multiple interactions ISO Flufenamic Acid inhibits the reaction [[KISS1 protein results in increased activity of KISS1R protein] which results in increased abundance of Calcium] CTD PMID:18948403 NCBI chr 7:12,606,210...12,609,868
Ensembl chr 7:12,606,210...12,609,868
JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
increases expression
ISO Flufenamic Acid inhibits the reaction [Cyclosporine inhibits the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]]; Flufenamic Acid promotes the reaction [[Cholesterol, LDL binds to LDLR protein] which results in increased degradation of Cholesterol, LDL]; Flufenamic Acid promotes the reaction [Cholesterol, LDL binds to LDLR protein]
Flufenamic Acid results in increased expression of LDLR mRNA; Flufenamic Acid results in increased expression of LDLR protein
CTD PMID:10395027 NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
JBrowse link
G Lep leptin multiple interactions ISO Flufenamic Acid inhibits the reaction [LEP protein results in increased transport of Calcium] CTD PMID:20107083 NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions EXP [Flufenamic Acid results in decreased abundance of Cyclic AMP] which results in decreased expression of LHB mRNA CTD PMID:8404651 NCBI chr 1:101,409,992...101,413,725
Ensembl chr 1:101,410,019...101,413,724
JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 NCBI chr15:51,065,316...51,067,908
Ensembl chr15:51,065,316...51,068,421
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression
ISO
EXP
Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
Flufenamic Acid results in increased expression of NOS2 mRNA
CTD PMID:10866999, PMID:15135310 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
JBrowse link
G Panx1 Pannexin 1 decreases activity ISO Flufenamic Acid results in decreased activity of PANX1 protein CTD PMID:19023039 NCBI chr 8:13,567,185...13,606,040
Ensembl chr 8:13,566,739...13,606,040
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO Flufenamic Acid binds to and results in increased activity of PPARA protein CTD PMID:9013583 NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
increases activity
ISO [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid binds to and results in increased activity of PPARG protein CTD PMID:9013583, PMID:10866999 NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein; Flufenamic Acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
Flufenamic Acid results in increased expression of PTGS2 mRNA; Flufenamic Acid results in increased expression of PTGS2 protein
CTD PMID:10866999 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
JBrowse link
G Sell selectin L decreases expression ISO Flufenamic Acid results in decreased expression of SELL protein CTD PMID:12147693 NCBI chr13:82,369,820...82,387,774
Ensembl chr13:82,369,493...82,387,631
JBrowse link
G Slc6a11 solute carrier family 6 member 11 multiple interactions ISO Flufenamic Acid inhibits the reaction [SLC6A11 protein results in increased uptake of gamma-Aminobutyric Acid] CTD PMID:15981712 NCBI chr 4:146,106,386...146,223,228
Ensembl chr 4:146,106,386...146,223,228
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
ISO
EXP
Flufenamic Acid inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
Flufenamic Acid results in increased expression of TNF mRNA
CTD PMID:10866999, PMID:15135310 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 multiple interactions
increases activity
ISO
EXP
[Flufenamic Acid results in increased activity of TRPC6 protein] which results in increased uptake of Calcium
Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Calcium]]; Flufenamic Acid inhibits the reaction [1-oleoyl-2-acetoyl-sn-glycerol promotes the reaction [TRPC6 protein results in increased uptake of Manganese]]
CTD PMID:11535132, PMID:14551041, PMID:21562303 NCBI chr 8:6,811,543...6,917,534
Ensembl chr 8:6,811,543...6,917,535
JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions EXP Flufenamic Acid inhibits the reaction [Adenosine Diphosphate Ribose promotes the reaction [TRPM2 protein results in increased transport of Calcium]] CTD PMID:21900507 NCBI chr20:11,434,062...11,482,880
Ensembl chr20:11,436,267...11,482,051
JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 decreases activity ISO
EXP
Flufenamic Acid results in decreased activity of TRPM4 protein CTD PMID:16966582, PMID:17188667 NCBI chr 1:101,293,300...101,323,484
Ensembl chr 1:101,293,409...101,323,960
JBrowse link
glafenine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin increases expression EXP Glafenine results in increased expression of A2M mRNA CTD PMID:24136188 NCBI chr 4:154,309,426...154,359,138
Ensembl chr 4:154,309,426...154,359,137
JBrowse link
G Aadac arylacetamide deacetylase decreases expression EXP Glafenine results in decreased expression of AADAC mRNA CTD PMID:24136188 NCBI chr 2:150,146,234...150,157,480
Ensembl chr 2:150,146,234...150,157,480
JBrowse link
G Aamdc adipogenesis associated, Mth938 domain containing decreases expression EXP Glafenine results in decreased expression of AAMDC mRNA CTD PMID:24136188 NCBI chr 1:162,519,513...162,549,211
Ensembl chr 1:162,519,521...162,533,893
JBrowse link
G Abat 4-aminobutyrate aminotransferase decreases expression EXP Glafenine results in decreased expression of ABAT mRNA CTD PMID:24136188 NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 increases expression EXP Glafenine results in increased expression of ABCA1 mRNA CTD PMID:24136188 NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases expression EXP Glafenine results in decreased expression of ABCB11 mRNA CTD PMID:24136188 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression EXP Glafenine results in decreased expression of ABCB1 mRNA CTD PMID:24136188 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 decreases expression EXP Glafenine results in decreased expression of ABCC2 mRNA CTD PMID:24136188 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression EXP Glafenine results in decreased expression of ABCD3 mRNA CTD PMID:24136188 NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 decreases expression EXP Glafenine results in decreased expression of ABCG5 mRNA CTD PMID:24136188 NCBI chr 6:7,935,771...7,961,207
Ensembl chr 6:7,935,771...7,961,207
JBrowse link
G Abhd1 abhydrolase domain containing 1 decreases expression EXP Glafenine results in decreased expression of ABHD1 mRNA CTD PMID:24136188 NCBI chr 6:26,787,807...26,792,795
Ensembl chr 6:26,784,058...26,792,808
JBrowse link
G Abhd14b abhydrolase domain containing 14b decreases expression EXP Glafenine results in decreased expression of ABHD14B mRNA CTD PMID:24136188 NCBI chr 8:115,149,638...115,154,556
Ensembl chr 8:115,150,514...115,154,550
JBrowse link
G Abhd2 abhydrolase domain containing 2, acylglycerol lipase increases expression EXP Glafenine results in increased expression of ABHD2 mRNA CTD PMID:24136188 NCBI chr 1:140,998,240...141,087,405
Ensembl chr 1:140,998,240...141,087,405
JBrowse link
G Abhd6 abhydrolase domain containing 6, acylglycerol lipase decreases expression EXP Glafenine results in decreased expression of ABHD6 mRNA CTD PMID:24136188 NCBI chr15:18,647,903...18,695,133
Ensembl chr15:18,647,844...18,695,133
JBrowse link
G Abi1 abl-interactor 1 decreases expression EXP Glafenine results in decreased expression of ABI1 mRNA CTD PMID:24136188 NCBI chr17:89,951,662...90,033,334
Ensembl chr17:89,951,752...90,033,328
JBrowse link
G Abraxas2 abraxas 2, BRISC complex subunit decreases expression EXP Glafenine results in decreased expression of ABRAXAS2 mRNA CTD PMID:24136188 NCBI chr 1:204,861,768...204,887,344
Ensembl chr 1:204,861,566...204,887,377
JBrowse link
G Abtb1 ankyrin repeat and BTB domain containing 1 decreases expression EXP Glafenine results in decreased expression of ABTB1 mRNA CTD PMID:24136188 NCBI chr 4:120,778,580...120,784,807
Ensembl chr 4:120,778,580...120,784,807
JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 decreases expression EXP Glafenine results in decreased expression of ABTB2 mRNA CTD PMID:24136188 NCBI chr 3:93,494,706...93,648,750
Ensembl chr 3:93,495,106...93,647,721
JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A decreases expression EXP Glafenine results in decreased expression of ACAA1 mRNA CTD PMID:24136188 NCBI chr 8:128,027,880...128,036,471
Ensembl chr 8:128,027,958...128,036,236
JBrowse link
G Acaca acetyl-CoA carboxylase alpha increases expression EXP Glafenine results in increased expression of ACACA mRNA CTD PMID:24136188 NCBI chr10:71,519,392...71,719,910
Ensembl chr10:71,536,533...71,719,910
JBrowse link
G Acad10 acyl-CoA dehydrogenase family, member 10 decreases expression EXP Glafenine results in decreased expression of ACAD10 mRNA CTD PMID:24136188 NCBI chr12:40,417,918...40,460,562
Ensembl chr12:40,417,944...40,460,561
JBrowse link
G Acad11 acyl-CoA dehydrogenase family, member 11 decreases expression EXP Glafenine results in decreased expression of ACAD11 mRNA CTD PMID:24136188 NCBI chr 8:112,594,758...112,676,275
Ensembl chr 8:112,594,691...112,676,280
JBrowse link
G Acad9 acyl-CoA dehydrogenase family, member 9 decreases expression EXP Glafenine results in decreased expression of ACAD9 mRNA CTD PMID:24136188 NCBI chr 2:122,782,051...122,806,166
Ensembl chr 2:122,782,060...122,805,768
JBrowse link
G Acadm acyl-CoA dehydrogenase medium chain decreases expression EXP Glafenine results in decreased expression of ACADM mRNA CTD PMID:24136188 NCBI chr 2:260,124,418...260,148,589
Ensembl chr 2:260,124,418...260,148,589
JBrowse link
G Acads acyl-CoA dehydrogenase short chain decreases expression EXP Glafenine results in decreased expression of ACADS mRNA CTD PMID:24136188 NCBI chr12:47,254,503...47,263,747
Ensembl chr12:47,254,484...47,263,747
JBrowse link
G Acbd5 acyl-CoA binding domain containing 5 decreases expression EXP Glafenine results in decreased expression of ACBD5 mRNA CTD PMID:24136188 NCBI chr17:89,882,465...89,923,982
Ensembl chr17:89,883,615...89,923,423
JBrowse link
G Acer2 alkaline ceramidase 2 increases expression EXP Glafenine results in increased expression of ACER2 mRNA CTD PMID:24136188 NCBI chr 5:105,230,540...105,279,732
Ensembl chr 5:105,230,580...105,279,731
JBrowse link
G Ackr3 atypical chemokine receptor 3 increases expression EXP Glafenine results in increased expression of ACKR3 mRNA CTD PMID:24136188 NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445
JBrowse link
G Acot12 acyl-CoA thioesterase 12 decreases expression EXP Glafenine results in decreased expression of ACOT12 mRNA CTD PMID:24136188 NCBI chr 2:20,857,056...20,901,656
Ensembl chr 2:20,857,202...20,901,659
JBrowse link
G Acot2 acyl-CoA thioesterase 2 decreases expression EXP Glafenine results in decreased expression of ACOT2 mRNA CTD PMID:24136188 NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
JBrowse link
G Acot4 acyl-CoA thioesterase 4 decreases expression EXP Glafenine results in decreased expression of ACOT4 mRNA CTD PMID:24136188 NCBI chr 6:107,517,668...107,522,952
Ensembl chr 6:107,517,668...107,522,952
JBrowse link
G Acox1 acyl-CoA oxidase 1 decreases expression EXP Glafenine results in decreased expression of ACOX1 mRNA CTD PMID:24136188 NCBI chr10:104,724,534...104,748,003
Ensembl chr10:104,722,958...104,748,050
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression EXP Glafenine results in decreased expression of ACSL1 mRNA CTD PMID:24136188 NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 decreases expression EXP Glafenine results in decreased expression of ACSM2A mRNA CTD PMID:24136188 NCBI chr 1:189,289,957...189,329,007
Ensembl chr 1:189,289,957...189,395,276
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 decreases expression EXP Glafenine results in decreased expression of ACSS2 mRNA CTD PMID:24136188 NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
JBrowse link
G Actg1 actin, gamma 1 increases expression EXP Glafenine results in increased expression of ACTG1 mRNA CTD PMID:24136188 NCBI chr10:109,518,429...109,521,288
Ensembl chr 3:75,643,054...75,644,954
Ensembl chr10:75,643,054...75,644,954
JBrowse link
G Adck5 aarF domain containing kinase 5 decreases expression EXP Glafenine results in decreased expression of ADCK5 mRNA CTD PMID:24136188 NCBI chr 7:117,643,976...117,661,789
Ensembl chr 7:117,643,206...117,661,845
JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide decreases expression EXP Glafenine results in decreased expression of ADH4 mRNA CTD PMID:24136188 NCBI chr 2:243,702,035...243,720,063
Ensembl chr 2:243,700,784...243,740,899
JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression EXP Glafenine results in decreased expression of ADHFE1 mRNA CTD PMID:24136188 NCBI chr 5:9,403,194...9,429,783
Ensembl chr 5:9,403,196...9,429,859
JBrowse link
G Adipor2 adiponectin receptor 2 decreases expression EXP Glafenine results in decreased expression of ADIPOR2 mRNA CTD PMID:24136188 NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
JBrowse link
G Adk adenosine kinase decreases expression EXP Glafenine results in decreased expression of ADK mRNA CTD PMID:24136188 NCBI chr15:3,033,535...3,435,888
Ensembl chr15:3,033,495...3,435,888
JBrowse link
G Adss adenylosuccinate synthase decreases expression EXP Glafenine results in decreased expression of ADSS mRNA CTD PMID:24136188 NCBI chr13:95,913,426...95,943,761
Ensembl chr13:95,913,426...95,943,761
JBrowse link
G Adssl1 adenylosuccinate synthase like 1 decreases expression EXP Glafenine results in decreased expression of ADSSL1 mRNA CTD PMID:24136188 NCBI chr 6:137,184,818...137,206,694
Ensembl chr 6:137,184,820...137,206,693
JBrowse link
G Adtrp androgen-dependent TFPI-regulating protein decreases expression EXP Glafenine results in decreased expression of ADTRP mRNA CTD PMID:24136188 NCBI chr17:22,619,913...22,688,296
Ensembl chr17:22,619,891...22,688,307
JBrowse link
G Afm afamin decreases expression EXP Glafenine results in decreased expression of AFM mRNA CTD PMID:24136188 NCBI chr14:19,078,678...19,132,212
Ensembl chr14:19,078,680...19,132,208
JBrowse link
G Afmid arylformamidase decreases expression EXP Glafenine results in decreased expression of AFMID mRNA CTD PMID:24136188 NCBI chr10:106,828,963...106,844,314
Ensembl chr10:106,828,981...106,844,314
JBrowse link
G Agmat agmatinase decreases expression EXP Glafenine results in decreased expression of AGMAT mRNA CTD PMID:24136188 NCBI chr 5:160,306,754...160,321,951
Ensembl chr 5:160,306,727...160,321,066
JBrowse link
G Agmo alkylglycerol monooxygenase decreases expression EXP Glafenine results in decreased expression of AGMO mRNA CTD PMID:24136188 NCBI chr 6:56,846,859...57,193,918
Ensembl chr 6:56,846,789...57,193,961
JBrowse link
G Ahcy adenosylhomocysteinase decreases expression EXP Glafenine results in decreased expression of AHCY mRNA CTD PMID:24136188 NCBI chr 3:150,587,833...150,603,057
Ensembl chr 3:150,587,833...150,603,082
JBrowse link
G Aimp2 aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 increases expression EXP Glafenine results in increased expression of AIMP2 mRNA CTD PMID:24136188 NCBI chr12:12,738,784...12,748,345
Ensembl chr12:12,738,812...12,748,345
JBrowse link
G Ak3 adenylate kinase 3 decreases expression EXP Glafenine results in decreased expression of AK3 mRNA CTD PMID:24136188 NCBI chr 1:247,144,486...247,169,690
Ensembl chr 1:247,144,491...247,169,693
JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 increases expression EXP Glafenine results in increased expression of AKR1A1 mRNA CTD PMID:24136188 NCBI chr 5:135,482,068...135,498,693
Ensembl chr 5:135,482,068...135,498,822
JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 decreases expression EXP Glafenine results in decreased expression of AKR1C1 mRNA CTD PMID:24136188 NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
JBrowse link
G Akr1e2 aldo-keto reductase family 1, member E2 decreases expression EXP Glafenine results in decreased expression of AKR1E2 mRNA CTD PMID:24136188 NCBI chr17:69,365,437...69,379,944
Ensembl chr17:69,365,453...69,379,947
JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 decreases expression EXP Glafenine results in decreased expression of AKR7A2 mRNA CTD PMID:24136188 NCBI chr 5:157,759,448...157,768,473
Ensembl chr 5:157,759,416...157,768,471
JBrowse link
G Akr7a3 aldo-keto reductase family 7 member A3 decreases expression EXP Glafenine results in decreased expression of AKR7A3 mRNA CTD PMID:24136188 NCBI chr 5:157,801,120...157,813,756
Ensembl chr 5:157,801,163...157,813,756
JBrowse link
G Alas1 5'-aminolevulinate synthase 1 decreases expression EXP Glafenine results in decreased expression of ALAS1 mRNA CTD PMID:24136188 NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH1A1 mRNA CTD PMID:24136188 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 decreases expression EXP Glafenine results in decreased expression of ALDH1L1 mRNA CTD PMID:24136188 NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression EXP Glafenine results in decreased expression of ALDH2 mRNA CTD PMID:24136188 NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752
JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 decreases expression EXP Glafenine results in decreased expression of ALDH3A2 mRNA CTD PMID:24136188 NCBI chr10:47,525,486...47,546,535
Ensembl chr10:47,525,493...47,546,345
JBrowse link
G Aldh4a1 aldehyde dehydrogenase 4 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH4A1 mRNA CTD PMID:24136188 NCBI chr 5:158,090,238...158,115,725
Ensembl chr 5:158,042,587...158,135,733
JBrowse link
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH5A1 mRNA CTD PMID:24136188 NCBI chr17:42,133,076...42,159,413
Ensembl chr17:42,133,076...42,159,413
JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH6A1 mRNA CTD PMID:24136188 NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 decreases expression EXP Glafenine results in decreased expression of ALDH9A1 mRNA CTD PMID:24136188 NCBI chr13:85,580,828...85,597,497
Ensembl chr13:85,580,828...85,597,493
JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression EXP Glafenine results in increased expression of ALDOA mRNA CTD PMID:24136188 NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG12 mRNA CTD PMID:24136188 NCBI chr 7:129,798,663...129,812,677
Ensembl chr 7:129,798,663...129,812,388
JBrowse link
G Alg2 ALG2, alpha-1,3/1,6-mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG2 mRNA CTD PMID:24136188 NCBI chr 5:63,187,466...63,192,025
Ensembl chr 5:63,187,468...63,192,025
JBrowse link
G Alg3 ALG3, alpha-1,3- mannosyltransferase increases expression EXP Glafenine results in increased expression of ALG3 mRNA CTD PMID:24136188 NCBI chr11:83,985,484...83,991,706
Ensembl chr11:83,986,230...83,991,706
JBrowse link
G Amacr alpha-methylacyl-CoA racemase decreases expression EXP Glafenine results in decreased expression of AMACR mRNA CTD PMID:24136188 NCBI chr 2:60,949,276...60,961,342
Ensembl chr 2:60,949,256...60,961,326
JBrowse link
G Amigo3 adhesion molecule with Ig like domain 3 increases expression EXP Glafenine results in increased expression of AMIGO3 mRNA CTD PMID:24136188 NCBI chr 8:116,830,773...116,832,299 JBrowse link
G Amy2a3 amylase 2a3 decreases expression EXP Glafenine results in decreased expression of AMY1A mRNA CTD PMID:24136188 NCBI chr 2:216,373,674...216,382,260
Ensembl chr 2:216,339,154...216,382,260
JBrowse link
G Ang angiogenin decreases expression EXP Glafenine results in decreased expression of ANG mRNA CTD PMID:24136188 NCBI chr15:28,022,926...28,028,636 JBrowse link
G Angptl3 angiopoietin-like 3 decreases expression EXP Glafenine results in decreased expression of ANGPTL3 mRNA CTD PMID:24136188 NCBI chr 5:117,698,590...117,706,729
Ensembl chr 5:117,698,764...117,705,808
JBrowse link
G Ankrd24 ankyrin repeat domain 24 increases expression EXP Glafenine results in increased expression of ANKRD24 mRNA CTD PMID:24136188 NCBI chr 7:10,917,359...10,937,522
Ensembl chr 7:10,917,367...10,936,415
JBrowse link
G Ankrd46 ankyrin repeat domain 46 decreases expression EXP Glafenine results in decreased expression of ANKRD46 mRNA CTD PMID:24136188 NCBI chr 7:75,279,443...75,300,442
Ensembl chr 7:75,279,446...75,288,365
JBrowse link
G Anks4b ankyrin repeat and sterile alpha motif domain containing 4B decreases expression EXP Glafenine results in decreased expression of ANKS4B mRNA CTD PMID:24136188 NCBI chr 1:189,940,305...189,942,113
Ensembl chr 1:189,940,291...189,942,112
JBrowse link
G Antxr2 ANTXR cell adhesion molecule 2 decreases expression EXP Glafenine results in decreased expression of ANTXR2 mRNA CTD PMID:24136188 NCBI chr14:13,191,716...13,331,286
Ensembl chr14:13,192,347...13,274,978
JBrowse link
G Anxa4 annexin A4 decreases expression EXP Glafenine results in decreased expression of ANXA4 mRNA CTD PMID:24136188 NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580
JBrowse link
G Apeg3 antisense paternally expressed gene 3 increases expression EXP Glafenine results in increased expression of APEG3 mRNA CTD PMID:24136188 NCBI chr 1:70,234,160...70,235,091
Ensembl chr 1:70,234,160...70,235,091
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP Glafenine results in increased expression of APEX1 mRNA CTD PMID:24136188 NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
JBrowse link
G Apmap adipocyte plasma membrane associated protein decreases expression EXP Glafenine results in decreased expression of APMAP mRNA CTD PMID:24136188 NCBI chr 3:146,376,828...146,407,259
Ensembl chr 3:146,376,828...146,407,252
JBrowse link
G Apoa2 apolipoprotein A2 decreases expression EXP Glafenine results in decreased expression of APOA2 mRNA CTD PMID:24136188 NCBI chr13:89,596,872...89,598,805
Ensembl chr13:89,597,138...89,598,802
JBrowse link
G Appbp2 amyloid beta precursor protein binding protein 2 decreases expression EXP Glafenine results in decreased expression of APPBP2 mRNA CTD PMID:24136188 NCBI chr10:72,503,347...72,545,141
Ensembl chr10:72,503,347...72,545,141
JBrowse link
G Aprt adenine phosphoribosyl transferase increases expression EXP Glafenine results in increased expression of APRT mRNA CTD PMID:24136188 NCBI chr19:55,387,288...55,389,256
Ensembl chr19:55,387,288...55,389,256
JBrowse link
G Arf4 ADP-ribosylation factor 4 increases expression EXP Glafenine results in increased expression of ARF4 mRNA CTD PMID:24136188 NCBI chr16:2,338,333...2,354,909
Ensembl chr16:2,338,333...2,354,909
JBrowse link
G Arfgap3 ADP-ribosylation factor GTPase activating protein 3 increases expression EXP Glafenine results in increased expression of ARFGAP3 mRNA CTD PMID:24136188 NCBI chr 7:124,149,665...124,198,298
Ensembl chr 7:124,149,751...124,198,200
JBrowse link
G Arfgef1 ADP ribosylation factor guanine nucleotide exchange factor 1 decreases expression EXP Glafenine results in decreased expression of ARFGEF1 mRNA CTD PMID:24136188 NCBI chr 5:8,666,046...8,760,458
Ensembl chr 5:8,666,200...8,760,458
JBrowse link
G Arfip2 ADP-ribosylation factor interacting protein 2 increases expression EXP Glafenine results in increased expression of ARFIP2 mRNA CTD PMID:24136188 NCBI chr 1:170,464,995...170,471,138
Ensembl chr 1:170,466,395...170,471,076
JBrowse link
G Arhgap1 Rho GTPase activating protein 1 increases expression EXP Glafenine results in increased expression of ARHGAP1 mRNA CTD PMID:24136188 NCBI chr 3:80,555,196...80,576,881
Ensembl chr 3:80,555,196...80,576,856
JBrowse link
G Arhgap18 Rho GTPase activating protein 18 decreases expression EXP Glafenine results in decreased expression of ARHGAP18 mRNA CTD PMID:24136188 NCBI chr 1:19,227,115...19,463,139
Ensembl chr 1:19,227,121...19,376,301
JBrowse link
G Arhgap24 Rho GTPase activating protein 24 decreases expression EXP Glafenine results in decreased expression of ARHGAP24 mRNA CTD PMID:24136188 NCBI chr14:8,383,211...8,600,526
Ensembl chr14:8,383,214...8,600,512
JBrowse link
G Arl6ip1 ADP-ribosylation factor like GTPase 6 interacting protein 1 decreases expression EXP Glafenine results in decreased expression of ARL6IP1 mRNA CTD PMID:24136188 NCBI chr 1:187,770,160...187,779,675
Ensembl chr 1:187,770,160...187,779,675
JBrowse link
G Arl6ip4 ADP-ribosylation factor like GTPase 6 interacting protein 4 increases expression EXP Glafenine results in increased expression of ARL6IP4 mRNA CTD PMID:24136188 NCBI chr12:37,904,376...37,906,521
Ensembl chr12:37,904,379...37,906,521
JBrowse link
G Armc9 armadillo repeat containing 9 increases expression EXP Glafenine results in increased expression of ARMC9 mRNA CTD PMID:24136188 NCBI chr 9:93,172,718...93,299,119
Ensembl chr 9:93,172,673...93,296,750
JBrowse link
G Armcx3 armadillo repeat containing, X-linked 3 increases expression EXP Glafenine results in increased expression of ARMCX3 mRNA CTD PMID:24136188 NCBI chr  X:105,573,909...105,577,480
Ensembl chr  X:105,573,909...105,580,562
JBrowse link
G Arpc1b actin related protein 2/3 complex, subunit 1B increases expression EXP Glafenine results in increased expression of ARPC1B mRNA CTD PMID:24136188 NCBI chr12:11,252,300...11,265,849
Ensembl chr12:11,252,296...11,265,865
JBrowse link
G Arpc5l actin related protein 2/3 complex, subunit 5-like increases expression EXP Glafenine results in increased expression of ARPC5L mRNA CTD PMID:24136188 NCBI chr 3:23,301,455...23,309,077
Ensembl chr 3:23,301,455...23,309,072
JBrowse link
G Asl argininosuccinate lyase decreases expression EXP Glafenine results in decreased expression of ASL mRNA CTD PMID:24136188 NCBI chr12:30,160,922...30,178,348
Ensembl chr12:30,165,694...30,178,341
JBrowse link
G Ass1 argininosuccinate synthase 1 decreases expression EXP Glafenine results in decreased expression of ASS1 mRNA CTD PMID:24136188 NCBI chr 3:10,327,411...10,375,847
Ensembl chr 3:10,327,414...10,375,826
JBrowse link
G Atf4 activating transcription factor 4 increases expression EXP Glafenine results in increased expression of ATF4 mRNA CTD PMID:24136188 NCBI chr 7:121,480,723...121,482,781
Ensembl chr 7:121,480,723...121,482,772
JBrowse link
G Atg13 autophagy related 13 increases expression EXP Glafenine results in increased expression of ATG13 mRNA CTD PMID:24136188 NCBI chr 3:80,580,549...80,614,554
Ensembl chr 3:80,581,247...80,601,410
JBrowse link
G Atg16l2 autophagy related 16-like 2 increases expression EXP Glafenine results in increased expression of ATG16L2 mRNA CTD PMID:24136188 NCBI chr 1:166,401,271...166,415,078
Ensembl chr 1:166,401,271...166,413,564
JBrowse link
G Atg2b autophagy related 2B decreases expression EXP Glafenine results in decreased expression of ATG2B mRNA CTD PMID:24136188 NCBI chr 6:129,449,451...129,519,599
Ensembl chr 6:129,449,449...129,509,720
JBrowse link
G Atl2 atlastin GTPase 2 decreases expression EXP Glafenine results in decreased expression of ATL2 mRNA CTD PMID:24136188 NCBI chr 6:2,568,975...2,610,432
Ensembl chr 6:2,568,990...2,610,437
JBrowse link
G Atp11a ATPase phospholipid transporting 11A decreases expression EXP Glafenine results in decreased expression of ATP11A mRNA CTD PMID:24136188 NCBI chr16:81,990,340...82,100,222
Ensembl chr16:81,990,340...82,100,222
JBrowse link
G Atp11c ATPase phospholipid transporting 11C decreases expression EXP Glafenine results in decreased expression of ATP11C mRNA CTD PMID:24136188 NCBI chr  X:143,340,712...143,525,588
Ensembl chr  X:143,346,252...143,453,612
JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression EXP Glafenine results in decreased expression of ATP1B1 mRNA CTD PMID:24136188 NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004
JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression EXP Glafenine results in increased expression of ATP2A2 mRNA CTD PMID:24136188 NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 increases expression EXP Glafenine results in increased expression of ATP5MC1 mRNA CTD PMID:24136188 NCBI chr10:83,895,941...83,898,640
Ensembl chr10:83,895,947...83,898,527
JBrowse link
G Atrn attractin decreases expression EXP Glafenine results in decreased expression of ATRN mRNA CTD PMID:24136188 NCBI chr 3:123,434,409...123,567,922
Ensembl chr 3:123,434,409...123,567,918
JBrowse link
G Atxn2 ataxin 2 decreases expression EXP Glafenine results in decreased expression of ATXN2 mRNA CTD PMID:24136188 NCBI chr12:40,264,601...40,335,637
Ensembl chr12:40,266,662...40,332,612
JBrowse link
G Aurkaip1 aurora kinase A interacting protein 1 increases expression EXP Glafenine results in increased expression of AURKAIP1 mRNA CTD PMID:24136188 NCBI chr 5:173,274,433...173,276,170
Ensembl chr 5:173,256,637...173,276,169
JBrowse link
G B2m beta-2 microglobulin decreases expression EXP Glafenine results in decreased expression of B2M mRNA CTD PMID:24136188 NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
JBrowse link
G B4galt1 beta-1,4-galactosyltransferase 1 increases expression EXP Glafenine results in increased expression of B4GALT1 mRNA CTD PMID:24136188 NCBI chr 5:57,121,768...57,168,610
Ensembl chr 5:57,121,769...57,168,610
JBrowse link
G B4gat1 beta-1,4-glucuronyltransferase 1 decreases expression EXP Glafenine results in decreased expression of B4GAT1 mRNA CTD PMID:24136188 NCBI chr 1:220,322,854...220,325,076
Ensembl chr 1:220,416,018...220,418,240
JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase decreases expression EXP Glafenine results in decreased expression of BAAT mRNA CTD PMID:24136188 NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
JBrowse link
G Babam1 BRISC and BRCA1 A complex member 1 increases expression EXP Glafenine results in increased expression of BABAM1 mRNA CTD PMID:24136188 NCBI chr16:19,792,720...19,798,886
Ensembl chr16:19,792,838...19,798,894
JBrowse link
G Basp1 brain abundant, membrane attached signal protein 1 increases expression EXP Glafenine results in increased expression of BASP1 mRNA CTD PMID:24136188 NCBI chr 2:77,586,424...77,632,626
Ensembl chr 2:77,586,424...77,632,628
JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 decreases expression EXP Glafenine results in decreased expression of BBOX1 mRNA CTD PMID:24136188 NCBI chr 3:101,425,684...101,474,848
Ensembl chr 3:101,427,055...101,474,890
JBrowse link
G Bbs2 Bardet-Biedl syndrome 2 decreases expression EXP Glafenine results in decreased expression of BBS2 mRNA CTD PMID:24136188 NCBI chr19:11,385,921...11,421,523
Ensembl chr19:11,386,024...11,421,498
JBrowse link
G Bcl3 BCL3, transcription coactivator increases expression EXP Glafenine results in increased expression of BCL3 mRNA CTD PMID:24136188 NCBI chr 1:80,730,758...80,745,273
Ensembl chr 1:80,730,499...80,744,831
JBrowse link
G Bet1l Bet1 golgi vesicular membrane trafficking protein-like increases expression EXP Glafenine results in increased expression of BET1L mRNA CTD PMID:24136188 NCBI chr 1:213,602,836...213,606,507
Ensembl chr 1:213,602,850...213,605,643
JBrowse link
G Bhlhe40 basic helix-loop-helix family, member e40 increases expression EXP Glafenine results in increased expression of BHLHE40 mRNA CTD PMID:24136188 NCBI chr 4:140,703,619...140,709,319
Ensembl chr 4:140,703,619...140,709,319
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase decreases expression EXP Glafenine results in decreased expression of BHMT mRNA CTD PMID:24136188 NCBI chr 2:23,236,573...23,256,158
Ensembl chr 2:23,236,575...23,256,158
JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 decreases expression EXP Glafenine results in decreased expression of BHMT2 mRNA CTD PMID:24136188 NCBI chr 2:23,272,320...23,289,266
Ensembl chr 2:23,272,328...23,289,266
JBrowse link
G Bloc1s5 biogenesis of lysosomal organelles complex 1 subunit 5 decreases expression EXP Glafenine results in decreased expression of BLOC1S5 mRNA CTD PMID:24136188 NCBI chr17:26,808,193...26,833,257
Ensembl chr17:26,808,330...26,833,247
JBrowse link
G Blvrb biliverdin reductase B decreases expression EXP Glafenine results in decreased expression of BLVRB mRNA CTD PMID:24136188 NCBI chr 1:84,256,063...84,273,726
Ensembl chr 1:84,256,159...84,274,075
JBrowse link
G Bnip1 BCL2 interacting protein 1 increases expression EXP Glafenine results in increased expression of BNIP1 mRNA CTD PMID:24136188 NCBI chr10:16,677,077...16,689,321
Ensembl chr10:16,677,077...16,689,321
JBrowse link
G Bnip3l BCL2 interacting protein 3 like decreases expression EXP Glafenine results in decreased expression of BNIP3L mRNA CTD PMID:24136188 NCBI chr15:43,643,897...43,667,123
Ensembl chr15:43,643,897...43,667,029
JBrowse link
G Bola3 bolA family member 3 increases expression EXP Glafenine results in increased expression of BOLA3 mRNA CTD PMID:24136188 NCBI chr 4:115,046,693...115,056,140
Ensembl chr 4:115,046,693...115,056,140
JBrowse link
G Bop1 BOP1 ribosomal biogenesis factor increases expression EXP Glafenine results in increased expression of BOP1 mRNA CTD PMID:24136188 NCBI chr 7:117,514,529...117,538,342
Ensembl chr 7:117,514,533...117,538,342
JBrowse link
G Borcs7 BLOC-1 related complex subunit 7 increases expression EXP Glafenine results in increased expression of BORCS7 mRNA CTD PMID:24136188 NCBI chr 1:266,451,021...266,464,903
Ensembl chr 1:266,451,021...266,464,903
JBrowse link
G Bphl biphenyl hydrolase like decreases expression EXP Glafenine results in decreased expression of BPHL mRNA CTD PMID:24136188 NCBI chr17:31,498,877...31,535,172
Ensembl chr17:31,498,883...31,535,172
JBrowse link
G Brd3 bromodomain containing 3 decreases expression EXP Glafenine results in decreased expression of BRD3 mRNA CTD PMID:24136188 NCBI chr 3:5,995,204...6,054,467
Ensembl chr 3:5,997,315...6,054,483
JBrowse link
G Brix1 biogenesis of ribosomes BRX1 increases expression EXP Glafenine results in increased expression of BRIX1 mRNA CTD PMID:24136188 NCBI chr 2:60,450,547...60,461,425
Ensembl chr 2:60,450,374...60,461,458
JBrowse link
G Btbd1 BTB domain containing 1 decreases expression EXP Glafenine results in decreased expression of BTBD1 mRNA CTD PMID:24136188 NCBI chr 1:143,609,729...143,647,124
Ensembl chr 1:143,609,731...143,647,124
JBrowse link
G Btbd11 BTB domain containing 11 decreases expression EXP Glafenine results in decreased expression of BTBD11 mRNA CTD PMID:24136188 NCBI chr 7:24,041,194...24,314,418
Ensembl chr 7:24,043,126...24,313,885
JBrowse link
G Btbd6 BTB domain containing 6 decreases expression EXP Glafenine results in decreased expression of BTBD6 mRNA CTD PMID:24136188 NCBI chr 6:137,785,662...137,788,442
Ensembl chr 6:137,785,982...137,788,434
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Glafenine results in increased expression of BTG2 mRNA CTD PMID:24136188 NCBI chr13:50,913,185...50,916,944
Ensembl chr13:50,913,180...50,916,982
JBrowse link
G Btg3 BTG anti-proliferation factor 3 increases expression EXP Glafenine results in increased expression of BTG3 mRNA CTD PMID:24136188 NCBI chr11:16,873,642...16,889,100
Ensembl chr11:16,873,646...16,889,201
JBrowse link
G Bysl bystin-like increases expression EXP Glafenine results in increased expression of BYSL mRNA CTD PMID:24136188 NCBI chr 9:15,393,461...15,403,212
Ensembl chr 9:15,393,330...15,403,117
JBrowse link
G C1qbp complement C1q binding protein increases expression EXP Glafenine results in increased expression of C1QBP mRNA CTD PMID:24136188 NCBI chr10:57,613,876...57,618,527
Ensembl chr10:57,613,879...57,618,527
JBrowse link
G C4bpb complement component 4 binding protein, beta increases expression EXP Glafenine results in increased expression of C4BPB mRNA CTD PMID:24136188 NCBI chr13:47,387,173...47,398,115
Ensembl chr13:47,387,173...47,397,890
JBrowse link
G C5 complement C5 increases expression EXP Glafenine results in increased expression of C5 mRNA CTD PMID:24136188 NCBI chr 3:14,049,993...14,113,931
NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
JBrowse link
G C9 complement C9 increases expression EXP Glafenine results in increased expression of C9 mRNA CTD PMID:24136188 NCBI chr 2:55,775,562...55,823,807
Ensembl chr 2:55,775,274...55,823,826
JBrowse link
G Ca14 carbonic anhydrase 14 decreases expression EXP Glafenine results in decreased expression of CAR14 mRNA CTD PMID:24136188 NCBI chr 2:198,010,142...198,017,635
Ensembl chr 2:198,010,349...198,016,898
JBrowse link
G Ca3 carbonic anhydrase 3 decreases expression EXP Glafenine results in decreased expression of CAR3 mRNA CTD PMID:24136188 NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
JBrowse link
G Ca5a carbonic anhydrase 5A decreases expression EXP Glafenine results in decreased expression of CAR5A mRNA CTD PMID:24136188 NCBI chr19:54,731,829...54,761,697
Ensembl chr19:54,731,859...54,761,670
JBrowse link
G Ca8 carbonic anhydrase 8 increases expression EXP Glafenine results in increased expression of CAR8 mRNA CTD PMID:24136188 NCBI chr 5:21,249,018...21,345,810
Ensembl chr 5:21,249,020...21,345,810
JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase increases expression EXP Glafenine results in increased expression of CAD mRNA CTD PMID:24136188 NCBI chr 6:26,657,507...26,680,459
Ensembl chr 6:26,657,780...26,680,284
JBrowse link
G Calm1 calmodulin 1 increases expression EXP Glafenine results in increased expression of CALM1 mRNA CTD PMID:24136188 NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292
JBrowse link
G Calr calreticulin increases expression EXP Glafenine results in increased expression of CALR mRNA CTD PMID:24136188 NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
JBrowse link
G Calu calumenin increases expression EXP Glafenine results in increased expression of CALU mRNA CTD PMID:24136188 NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
JBrowse link
G Caprin1 cell cycle associated protein 1 decreases expression EXP Glafenine results in decreased expression of CAPRIN1 mRNA CTD PMID:24136188 NCBI chr 3:93,701,830...93,789,580
Ensembl chr 3:93,702,487...93,789,617
JBrowse link
G Cars cysteinyl-tRNA synthetase increases expression EXP Glafenine results in increased expression of CARS mRNA CTD PMID:24136188 NCBI chr 1:216,759,367...216,801,652
Ensembl chr 1:216,759,366...216,801,656
JBrowse link
G Cars2 cysteinyl-tRNA synthetase 2, mitochondrial decreases expression EXP Glafenine results in decreased expression of CARS2 mRNA CTD PMID:24136188 NCBI chr16:83,288,613...83,325,706
Ensembl chr16:83,288,664...83,325,699
JBrowse link
G Cat catalase decreases expression EXP Glafenine results in decreased expression of CAT mRNA CTD PMID:24136188 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
JBrowse link
G Cav2 caveolin 2 increases expression EXP Glafenine results in increased expression of CAV2 mRNA CTD PMID:24136188 NCBI chr 4:44,573,264...44,580,640
Ensembl chr 4:44,573,264...44,580,638
JBrowse link
G Cbr4 carbonyl reductase 4 decreases expression EXP Glafenine results in decreased expression of CBR4 mRNA CTD PMID:24136188 NCBI chr16:31,944,328...31,972,553
Ensembl chr16:31,956,753...31,972,507
JBrowse link
G Ccdc125 coiled-coil domain containing 125 increases expression EXP Glafenine results in increased expression of CCDC125 mRNA CTD PMID:24136188 NCBI chr 2:30,685,845...30,726,617
Ensembl chr 2:30,685,840...30,704,487
JBrowse link
G Ccdc134 coiled-coil domain containing 134 increases expression EXP Glafenine results in increased expression of CCDC134 mRNA CTD PMID:24136188 NCBI chr 7:123,362,471...123,376,930
Ensembl chr 7:123,364,312...123,376,221
JBrowse link
G Ccdc167 coiled-coil domain containing 167 increases expression EXP Glafenine results in increased expression of CCDC167 mRNA CTD PMID:24136188 NCBI chr20:8,367,047...8,384,119
Ensembl chr20:8,369,331...8,384,088
JBrowse link
G Ccdc28a coiled-coil domain containing 28A decreases expression EXP Glafenine results in decreased expression of CCDC28A mRNA CTD PMID:24136188 NCBI chr 1:13,384,153...13,395,643
Ensembl chr 1:13,384,156...13,395,370
JBrowse link
G Ccdc86 coiled-coil domain containing 86 increases expression EXP Glafenine results in increased expression of CCDC86 mRNA CTD PMID:24136188 NCBI chr 1:226,996,435...227,002,016
Ensembl chr 1:226,996,237...227,002,139
JBrowse link
G Ccng2 cyclin G2 decreases expression EXP Glafenine results in decreased expression of CCNG2 mRNA CTD PMID:24136188 NCBI chr14:16,267,572...16,276,068
Ensembl chr14:16,267,573...16,276,068
JBrowse link
G Ccni cyclin I decreases expression EXP Glafenine results in decreased expression of CCNI mRNA CTD PMID:24136188 NCBI chr14:16,341,510...16,364,326
Ensembl chr14:16,341,536...16,364,326
JBrowse link
G Cd2bp2 Cd2 (cytoplasmic tail) binding protein 2 increases expression EXP Glafenine results in increased expression of CD2BP2 mRNA CTD PMID:24136188 NCBI chr 1:198,635,445...198,641,195
Ensembl chr 1:198,635,447...198,638,944
JBrowse link
G Cd48 Cd48 molecule increases expression EXP Glafenine results in increased expression of CD48 mRNA CTD PMID:24136188 NCBI chr13:90,116,601...90,140,371
Ensembl chr13:90,116,843...90,140,371
JBrowse link
G Cd59 CD59 molecule decreases expression EXP Glafenine results in decreased expression of CD59 mRNA CTD PMID:24136188 NCBI chr 3:94,010,481...94,028,660
Ensembl chr 3:94,010,475...94,028,621
JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 decreases expression EXP Glafenine results in decreased expression of CDADC1 mRNA CTD PMID:24136188 NCBI chr15:39,865,094...39,894,122
Ensembl chr15:39,882,210...39,893,979
JBrowse link
G Cdc42se1 CDC42 small effector 1 increases expression EXP Glafenine results in increased expression of CDC42SE1 mRNA CTD PMID:24136188 NCBI chr 2:196,402,837...196,410,664
Ensembl chr 2:196,402,837...196,410,659
JBrowse link
G Cdc5l cell division cycle 5-like decreases expression EXP Glafenine results in decreased expression of CDC5L mRNA CTD PMID:24136188 NCBI chr 9:17,949,764...17,988,514
Ensembl chr 9:17,949,764...17,988,509
JBrowse link
G Cdh2 cadherin 2 decreases expression EXP Glafenine results in decreased expression of CDH2 mRNA CTD PMID:24136188 NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
JBrowse link
G Cdip1 cell death-inducing p53 target 1 decreases expression EXP Glafenine results in decreased expression of CDIP1 mRNA CTD PMID:24136188 NCBI chr10:10,966,819...10,989,937
Ensembl chr10:10,967,658...10,989,936
JBrowse link
G Cdk2ap1 cyclin-dependent kinase 2 associated protein 1 increases expression EXP Glafenine results in increased expression of CDK2AP1 mRNA CTD PMID:24136188 NCBI chr12:37,668,369...37,677,067
Ensembl chr12:37,668,369...37,677,063
JBrowse link
G Cdk2ap2 cyclin-dependent kinase 2 associated protein 2 increases expression EXP Glafenine results in increased expression of CDK2AP2 mRNA CTD PMID:24136188 NCBI chr 1:219,345,638...219,347,709
Ensembl chr 1:219,345,918...219,347,728
JBrowse link
G Cdk4 cyclin-dependent kinase 4 increases expression EXP Glafenine results in increased expression of CDK4 mRNA CTD PMID:24136188 NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression EXP Glafenine results in increased expression of CDKN1A mRNA CTD PMID:24136188 NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B decreases expression EXP Glafenine results in decreased expression of CDKN1B mRNA CTD PMID:24136188 NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression EXP Glafenine results in decreased expression of CDKN3 mRNA CTD PMID:24136188 NCBI chr15:23,553,171...23,564,538
Ensembl chr15:23,553,128...23,564,535
JBrowse link
G Cdo1 cysteine dioxygenase type 1 decreases expression EXP Glafenine results in decreased expression of CDO1 mRNA CTD PMID:24136188 NCBI chr18:40,702,027...40,716,901
Ensembl chr18:40,701,984...40,716,686
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 decreases expression EXP Glafenine results in decreased expression of CEACAM1 mRNA CTD PMID:24136188 NCBI chr 1:82,327,955...82,344,345
Ensembl chr 1:82,327,955...82,344,345
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression EXP Glafenine results in increased expression of CEBPD mRNA CTD PMID:24136188 NCBI chr11:89,008,008...89,009,146
Ensembl chr11:89,008,008...89,009,146
JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 increases expression EXP Glafenine results in increased expression of CEMIP2 mRNA CTD PMID:24136188 NCBI chr 1:239,397,322...239,474,931
Ensembl chr 1:239,398,043...239,474,931
JBrowse link
G Cept1 choline/ethanolamine phosphotransferase 1 decreases expression EXP Glafenine results in decreased expression of CEPT1 mRNA CTD PMID:24136188 NCBI chr 2:209,118,140...209,162,071
Ensembl chr 2:209,118,922...209,160,653
JBrowse link
G Ces1d carboxylesterase 1D decreases expression EXP Glafenine results in decreased expression of CES1D mRNA CTD PMID:24136188 NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
JBrowse link
G Chac2 ChaC glutathione specific gamma-glutamylcyclotransferase 2 decreases expression EXP Glafenine results in decreased expression of CHAC2 mRNA CTD PMID:24136188 NCBI chr14:115,383,906...115,391,757
Ensembl chr14:115,383,910...115,391,652
JBrowse link
G Chchd6 coiled-coil-helix-coiled-coil-helix domain containing 6 increases expression EXP Glafenine results in increased expression of CHCHD6 mRNA CTD PMID:24136188 NCBI chr 4:121,340,952...121,565,222
Ensembl chr 4:121,340,952...121,565,212
JBrowse link
G Chid1 chitinase domain containing 1 increases expression EXP Glafenine results in increased expression of CHID1 mRNA CTD PMID:24136188 NCBI chr 1:214,476,418...214,511,569
Ensembl chr 1:214,476,387...214,511,529
JBrowse link
G Chmp4c charged multivesicular body protein 4C decreases expression EXP Glafenine results in decreased expression of CHMP4C mRNA CTD PMID:24136188 NCBI chr 2:93,574,554...93,641,497
Ensembl chr 2:93,574,559...93,641,497
JBrowse link
G Chpf2 chondroitin polymerizing factor 2 increases expression EXP Glafenine results in increased expression of CHPF2 mRNA CTD PMID:24136188 NCBI chr 4:7,108,461...7,113,940
Ensembl chr 4:7,108,462...7,113,919
JBrowse link
G Cic capicua transcriptional repressor increases expression EXP Glafenine results in increased expression of CIC mRNA CTD PMID:24136188 NCBI chr 1:82,135,440...82,163,007
Ensembl chr 1:82,151,669...82,163,005
JBrowse link
G Cinp cyclin-dependent kinase 2-interacting protein increases expression EXP Glafenine results in increased expression of CINP mRNA CTD PMID:24136188 NCBI chr 6:135,290,528...135,304,422
Ensembl chr 6:135,290,530...135,304,422
JBrowse link
G Cisd2 CDGSH iron sulfur domain 2 increases expression EXP Glafenine results in increased expression of CISD2 mRNA CTD PMID:24136188 NCBI chr 2:240,586,754...240,611,560
Ensembl chr 2:240,586,754...240,611,560
JBrowse link
G Cks1b CDC28 protein kinase regulatory subunit 1B increases expression EXP Glafenine results in increased expression of CKS1B mRNA CTD PMID:24136188 NCBI chr 2:188,740,564...188,745,144
Ensembl chr 2:188,740,573...188,745,144
JBrowse link
G Clcn4 chloride voltage-gated channel 4 decreases expression EXP Glafenine results in decreased expression of CLCN4 mRNA CTD PMID:24136188 NCBI chr  X:25,016,177...25,082,563
Ensembl chr  X:25,016,401...25,080,410
JBrowse link
G Clic1 chloride intracellular channel 1 increases expression EXP Glafenine results in increased expression of CLIC1 mRNA CTD PMID:24136188 NCBI chr20:5,040,314...5,049,166
Ensembl chr20:5,040,337...5,049,166
JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit X decreases expression EXP Glafenine results in decreased expression of CLPX mRNA CTD PMID:24136188 NCBI chr 8:70,789,137...70,843,133
Ensembl chr 8:70,789,256...70,843,123
JBrowse link
G Cmbl carboxymethylenebutenolidase homolog decreases expression EXP Glafenine results in decreased expression of CMBL mRNA CTD PMID:24136188 NCBI chr 2:84,645,084...84,666,836
Ensembl chr 2:84,645,084...84,666,835
JBrowse link
G Cmtr1 cap methyltransferase 1 decreases expression EXP Glafenine results in decreased expression of CMTR1 mRNA CTD PMID:24136188 NCBI chr20:8,324,968...8,385,174
Ensembl chr20:8,312,792...8,368,764
JBrowse link
G Cnn2 calponin 2 increases expression EXP Glafenine results in increased expression of CNN2 mRNA CTD PMID:24136188 NCBI chr 7:12,782,459...12,787,977
Ensembl chr 7:12,782,491...12,787,750
JBrowse link
G Cnppd1 cyclin Pas1/PHO80 domain containing 1 decreases expression EXP Glafenine results in decreased expression of CNPPD1 mRNA CTD PMID:24136188 NCBI chr 9:82,338,865...82,345,262
Ensembl chr 9:82,338,866...82,345,262
JBrowse link
G Cnpy2 canopy FGF signaling regulator 2 increases expression EXP Glafenine results in increased expression of CNPY2 mRNA CTD PMID:24136188 NCBI chr 7:2,737,674...2,744,321
Ensembl chr 7:2,737,765...2,742,369
JBrowse link
G Cnpy3 canopy FGF signaling regulator 3 increases expression EXP Glafenine results in increased expression of CNPY3 mRNA CTD PMID:24136188 NCBI chr 9:16,543,715...16,558,441
Ensembl chr 9:16,543,688...16,558,456
JBrowse link
G Coasy Coenzyme A synthase decreases expression EXP Glafenine results in decreased expression of COASY mRNA CTD PMID:24136188 NCBI chr10:88,992,413...88,996,677
Ensembl chr10:88,992,487...88,996,676
JBrowse link
G Cog3 component of oligomeric golgi complex 3 increases expression EXP Glafenine results in increased expression of COG3 mRNA CTD PMID:24136188 NCBI chr15:57,753,814...57,805,627
Ensembl chr15:57,755,189...57,805,184
JBrowse link
G Cog4 component of oligomeric golgi complex 4 decreases expression EXP Glafenine results in decreased expression of COG4 mRNA CTD PMID:24136188 NCBI chr19:43,358,057...43,391,828
Ensembl chr19:43,358,057...43,391,828
JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain increases expression EXP Glafenine results in increased expression of COL18A1 mRNA CTD PMID:24136188 NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
JBrowse link
G Col4a1 collagen type IV alpha 1 chain increases expression EXP Glafenine results in increased expression of COL4A1 mRNA CTD PMID:24136188 NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
JBrowse link
G Copa COPI coat complex subunit alpha increases expression EXP Glafenine results in increased expression of COPA mRNA CTD PMID:24136188 NCBI chr13:90,467,285...90,508,894
Ensembl chr13:90,467,265...90,508,932
JBrowse link
G Cope COPI coat complex subunit epsilon increases expression EXP Glafenine results in increased expression of COPE mRNA CTD PMID:24136188 NCBI chr16:20,863,141...20,873,516
Ensembl chr16:20,863,141...20,873,521
JBrowse link
G Copg1 COPI coat complex subunit gamma 1 increases expression EXP Glafenine results in increased expression of COPG1 mRNA CTD PMID:24136188 NCBI chr 4:119,815,041...119,840,997
Ensembl chr 4:119,815,139...119,864,114
JBrowse link
G Copg2 COPI coat complex subunit gamma 2 decreases expression EXP Glafenine results in decreased expression of COPG2 mRNA CTD PMID:24136188 NCBI chr 4:58,064,394...58,195,242
Ensembl chr 4:58,064,833...58,195,143
JBrowse link
G Copz1 COPI coat complex subunit zeta 1 increases expression EXP Glafenine results in increased expression of COPZ1 mRNA CTD PMID:24136188 NCBI chr 7:144,900,050...144,926,299
Ensembl chr 7:144,899,534...144,926,350
JBrowse link
G Copz2 COPI coat complex subunit zeta 2 increases expression EXP Glafenine results in increased expression of COPZ2 mRNA CTD PMID:24136188 NCBI chr10:84,718,824...84,731,880
Ensembl chr10:84,718,824...84,731,880
JBrowse link
G Coq10a coenzyme Q10A decreases expression EXP Glafenine results in decreased expression of COQ10A mRNA CTD PMID:24136188 NCBI chr 7:2,780,930...2,788,189
Ensembl chr 7:2,780,930...2,786,949
JBrowse link
G Coq10b coenzyme Q10B increases expression EXP Glafenine results in increased expression of COQ10B mRNA CTD PMID:24136188 NCBI chr 9:61,655,963...61,675,880
Ensembl chr 9:61,655,963...61,675,873
JBrowse link
G Coq8a coenzyme Q8A decreases expression EXP Glafenine results in decreased expression of COQ8A mRNA CTD PMID:24136188 NCBI chr13:98,451,629...98,480,438
Ensembl chr13:98,451,637...98,480,419
JBrowse link
G Cotl1 coactosin-like F-actin binding protein 1 increases expression EXP Glafenine results in increased expression of COTL1 mRNA CTD PMID:24136188 NCBI chr19:52,465,074...52,499,433
Ensembl chr19:52,465,087...52,499,433
JBrowse link
G Cox5a cytochrome c oxidase subunit 5A decreases expression EXP Glafenine results in decreased expression of COX5A mRNA CTD PMID:24136188 NCBI chr 8:62,298,358...62,309,765
Ensembl chr 8:62,298,358...62,309,765
JBrowse link
G Cox5b cytochrome c oxidase subunit 5B increases expression EXP Glafenine results in increased expression of COX5B mRNA CTD PMID:24136188 NCBI chr 9:43,259,706...43,262,039
Ensembl chr 9:43,259,709...43,262,040
JBrowse link
G Cp ceruloplasmin increases expression EXP Glafenine results in increased expression of CP mRNA CTD PMID:24136188 NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853
JBrowse link
G Cpne3 copine 3 decreases expression EXP Glafenine results in decreased expression of CPNE3 mRNA CTD PMID:24136188 NCBI chr 5:33,525,307...33,574,610
Ensembl chr 5:33,528,154...33,574,596
JBrowse link
G Cpne8 copine 8 increases expression EXP Glafenine results in increased expression of CPNE8 mRNA CTD PMID:24136188 NCBI chr 7:131,623,180...131,798,236
Ensembl chr 7:131,623,181...131,798,236
JBrowse link
G Cpped1 calcineurin-like phosphoesterase domain containing 1 decreases expression EXP Glafenine results in decreased expression of CPPED1 mRNA CTD PMID:24136188 NCBI chr10:3,655,038...3,774,887
Ensembl chr10:3,655,038...3,774,884
JBrowse link
G Cpq carboxypeptidase Q decreases expression EXP Glafenine results in decreased expression of PGCP mRNA CTD PMID:24136188 NCBI chr 7:71,709,174...72,167,413
Ensembl chr 7:71,709,157...72,167,417
JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 decreases expression EXP Glafenine results in decreased expression of CPS1 mRNA CTD PMID:24136188 NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 decreases expression EXP Glafenine results in decreased expression of CPT2 mRNA CTD PMID:24136188 NCBI chr 5:127,505,646...127,523,016
Ensembl chr 5:127,505,614...127,523,089
JBrowse link
G Crat carnitine O-acetyltransferase decreases expression EXP Glafenine results in decreased expression of CRAT mRNA CTD PMID:24136188 NCBI chr 3:8,967,984...8,981,959
Ensembl chr 3:8,968,417...8,981,362
JBrowse link
G Crbn cereblon decreases expression EXP Glafenine results in decreased expression of CRBN mRNA CTD PMID:24136188 NCBI chr 4:138,864,910...138,885,786
Ensembl chr 4:138,866,761...138,885,556
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression EXP Glafenine results in decreased expression of CREB3L3 mRNA CTD PMID:24136188 NCBI chr 7:11,490,852...11,499,287
Ensembl chr 7:11,490,852...11,499,282
JBrowse link
G Crebzf CREB/ATF bZIP transcription factor decreases expression EXP Glafenine results in decreased expression of CREBZF mRNA CTD PMID:24136188 NCBI chr 1:156,290,215...156,296,891
Ensembl chr 1:156,294,519...156,296,161
JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 increases expression EXP Glafenine results in increased expression of CRELD2 mRNA CTD PMID:24136188 NCBI chr 7:129,812,746...129,819,641
Ensembl chr 7:129,812,789...129,819,634
JBrowse link
G Crem cAMP responsive element modulator decreases expression EXP Glafenine results in decreased expression of CREM mRNA CTD PMID:24136188 NCBI chr17:57,021,704...57,090,888
Ensembl chr17:57,031,766...57,090,888
JBrowse link
G Crls1 cardiolipin synthase 1 decreases expression EXP Glafenine results in decreased expression of CRLS1 mRNA CTD PMID:24136188 NCBI chr 3:125,503,638...125,522,460
Ensembl chr 3:125,503,638...125,522,441
JBrowse link
G Crot carnitine O-octanoyltransferase decreases expression EXP Glafenine results in decreased expression of CROT mRNA CTD PMID:24136188 NCBI chr 4:22,079,837...22,116,265
Ensembl chr 4:22,081,604...22,116,265
JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 decreases expression EXP Glafenine results in decreased expression of CRYBG2 mRNA CTD PMID:24136188 NCBI chr 5:152,289,492...152,321,539
Ensembl chr 5:152,290,084...152,321,541
JBrowse link
G Cryl1 crystallin, lambda 1 decreases expression EXP Glafenine results in decreased expression of CRYL1 mRNA CTD PMID:24136188 NCBI chr15:37,543,727...37,663,586
Ensembl chr15:37,543,727...37,663,584
JBrowse link
G Crym crystallin, mu decreases expression EXP Glafenine results in decreased expression of CRYM mRNA CTD PMID:24136188 NCBI chr 1:189,944,895...189,960,069
Ensembl chr 1:189,944,895...189,960,073
JBrowse link
G Cryz crystallin zeta decreases expression EXP Glafenine results in decreased expression of CRYZ mRNA CTD PMID:24136188 NCBI chr 2:260,884,315...260,911,827
Ensembl chr 2:260,884,337...260,911,792
JBrowse link
G Csf1 colony stimulating factor 1 increases expression EXP Glafenine results in increased expression of CSF1 mRNA CTD PMID:24136188 NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560
JBrowse link
G Ctbs chitobiase decreases expression EXP Glafenine results in decreased expression of CTBS mRNA CTD PMID:24136188 NCBI chr 2:252,305,874...252,320,387
Ensembl chr 2:252,305,874...252,320,387
JBrowse link
G Cth cystathionine gamma-lyase decreases expression EXP Glafenine results in decreased expression of CTH mRNA CTD PMID:24136188 NCBI chr 2:264,266,959...264,293,040
Ensembl chr 2:264,266,984...264,293,046
JBrowse link
G Ctnna1 catenin alpha 1 decreases expression EXP Glafenine results in decreased expression of CTNNA1 mRNA CTD PMID:24136188 NCBI chr18:27,923,229...28,055,972
Ensembl chr18:27,923,572...28,055,960
JBrowse link
G Ctps1 CTP synthase 1 increases expression EXP Glafenine results in increased expression of CTPS1 mRNA CTD PMID:24136188 NCBI chr 5:139,475,934...139,505,065
Ensembl chr 5:139,475,934...139,505,065
JBrowse link
G Ctsa cathepsin A decreases expression EXP Glafenine results in decreased expression of CTSA mRNA CTD PMID:24136188 NCBI chr 3:161,298,750...161,304,627
Ensembl chr 3:161,298,962...161,304,625
JBrowse link
G Ctsf cathepsin F decreases expression EXP Glafenine results in decreased expression of CTSF mRNA CTD PMID:24136188 NCBI chr 1:220,114,228...220,119,976
Ensembl chr 1:220,114,228...220,119,976
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 increases expression EXP Glafenine results in increased expression of CXCL1 mRNA CTD PMID:24136188 NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 decreases expression EXP Glafenine results in decreased expression of CXCL12 mRNA CTD PMID:24136188 NCBI chr 4:149,261,044...149,273,891
Ensembl chr 4:149,261,044...149,273,891
JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 decreases expression EXP Glafenine results in decreased expression of CXCL9 mRNA CTD PMID:24136188 NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 decreases expression EXP Glafenine results in decreased expression of CYB5R3 mRNA CTD PMID:24136188 NCBI chr 7:124,024,003...124,041,564
Ensembl chr 7:124,023,995...124,041,594
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP17A1 mRNA CTD PMID:24136188 NCBI chr 1:266,422,127...266,429,947
Ensembl chr 1:266,422,132...266,428,239
JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP27A1 mRNA CTD PMID:24136188 NCBI chr 9:81,968,285...81,998,213
Ensembl chr 9:81,968,332...81,998,169
JBrowse link
G Cyp2a1 cytochrome P450, family 2, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2A1 mRNA CTD PMID:24136188 NCBI chr 1:83,711,223...83,725,222
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2a2 cytochrome P450, family 2, subfamily a, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP2A2 mRNA CTD PMID:24136188 NCBI chr 1:83,744,229...83,766,490
Ensembl chr 1:83,653,234...83,766,484
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2B1 mRNA CTD PMID:24136188 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 decreases expression EXP Glafenine results in decreased expression of CYP2C11 mRNA CTD PMID:24136188 NCBI chr 1:257,676,172...258,004,428
Ensembl chr 1:257,970,345...258,004,434
JBrowse link
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2D1 mRNA CTD PMID:24136188 NCBI chr 7:123,625,641...123,630,045
Ensembl chr 7:123,625,590...123,638,765
JBrowse link
G Cyp2d2 cytochrome P450, family 2, subfamily d, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP2D2 mRNA CTD PMID:24136188 NCBI chr 7:123,651,827...123,655,896
Ensembl chr 7:123,651,827...123,655,896
JBrowse link
G Cyp2d3 cytochrome P450, family 2, subfamily d, polypeptide 3 decreases expression EXP Glafenine results in decreased expression of CYP2D3 mRNA CTD PMID:24136188 NCBI chr 7:123,634,400...123,638,757
Ensembl chr 7:123,625,590...123,638,765
JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP2D4 mRNA CTD PMID:24136188 NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2E1 mRNA CTD PMID:24136188 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
JBrowse link
G Cyp2j3 cytochrome P450, family 2, subfamily j, polypeptide 3 decreases expression EXP Glafenine results in decreased expression of CYP2J3 mRNA CTD PMID:24136188 NCBI chr 5:115,196,982...115,222,084 JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP2J4 mRNA CTD PMID:24136188 NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846
JBrowse link
G Cyp2t1 cytochrome P450, family 2, subfamily t, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP2T1 mRNA CTD PMID:24136188 NCBI chr 1:83,965,370...83,969,466
Ensembl chr 1:83,965,608...83,969,559
JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP39A1 mRNA CTD PMID:24136188 NCBI chr 9:19,804,079...19,880,346
Ensembl chr 9:19,804,079...19,880,346
JBrowse link
G Cyp3a18 cytochrome P450, family 3, subfamily a, polypeptide 18 decreases expression EXP Glafenine results in decreased expression of CYP3A18 mRNA CTD PMID:24136188 NCBI chr12:10,636,294...10,684,273
Ensembl chr12:10,636,275...10,684,278
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases expression EXP Glafenine results in decreased expression of CYP3A2 mRNA CTD PMID:24136188 NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP3A23-3A1 mRNA CTD PMID:24136188 NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 NCBI chr 5:134,492,734...134,507,158
Ensembl chr 5:134,492,756...134,507,154
JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 decreases expression EXP Glafenine results in decreased expression of CYP4F1 mRNA CTD PMID:24136188 NCBI chr 7:15,179,472...15,191,113
Ensembl chr 7:15,179,467...15,190,796
JBrowse link
G Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 decreases expression EXP Glafenine results in decreased expression of CYP4F4 mRNA CTD PMID:24136188 NCBI chr 7:14,891,062...14,907,250
Ensembl chr 7:14,891,001...14,907,305
JBrowse link
G Dad1 defender against cell death 1 increases expression EXP Glafenine results in increased expression of DAD1 mRNA CTD PMID:24136188 NCBI chr15:32,868,136...32,887,933
Ensembl chr15:32,868,087...32,888,095
JBrowse link
G Dao D-amino-acid oxidase decreases expression EXP Glafenine results in decreased expression of DAO mRNA CTD PMID:24136188 NCBI chr12:48,353,691...48,373,647
Ensembl chr12:48,354,196...48,365,784
JBrowse link
G Dap death-associated protein increases expression EXP Glafenine results in increased expression of DAP mRNA CTD PMID:24136188 NCBI chr 2:84,275,884...84,328,998
Ensembl chr 2:84,275,884...84,328,998
JBrowse link
G Dcaf11 DDB1 and CUL4 associated factor 11 decreases expression EXP Glafenine results in decreased expression of DCAF11 mRNA CTD PMID:24136188 NCBI chr15:34,233,840...34,244,512
Ensembl chr15:34,234,193...34,244,504
JBrowse link
G Dcaf6 DDB1 and CUL4 associated factor 6 decreases expression EXP Glafenine results in decreased expression of DCAF6 mRNA CTD PMID:24136188 NCBI chr13:83,578,730...83,680,330
Ensembl chr13:83,579,036...83,680,207
JBrowse link
G Dcun1d4 defective in cullin neddylation 1 domain containing 4 decreases expression EXP Glafenine results in decreased expression of DCUN1D4 mRNA CTD PMID:24136188 NCBI chr14:37,210,721...37,294,517
Ensembl chr14:37,210,721...37,294,472
JBrowse link
G Dda1 DET1 and DDB1 associated 1 increases expression EXP Glafenine results in increased expression of DDA1 mRNA CTD PMID:24136188 NCBI chr16:19,877,873...19,885,501
Ensembl chr16:19,881,122...19,885,500
JBrowse link
G Ddc dopa decarboxylase decreases expression EXP Glafenine results in decreased expression of DDC mRNA CTD PMID:24136188 NCBI chr14:91,905,919...91,996,816
Ensembl chr14:91,905,919...91,996,774
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO Glafenine results in increased expression of DDIT3 mRNA CTD PMID:24136188 NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
JBrowse link
G Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit increases expression EXP Glafenine results in increased expression of DDOST mRNA CTD PMID:24136188 NCBI chr 5:156,668,924...156,676,036
Ensembl chr 5:156,668,712...156,676,035
JBrowse link
G Ddx39a DExD-box helicase 39A increases expression EXP Glafenine results in increased expression of DDX39A mRNA CTD PMID:24136188 NCBI chr19:24,846,530...24,854,886
Ensembl chr19:24,846,938...24,854,953
JBrowse link
G Ddx39b DExD-box helicase 39B increases expression EXP Glafenine results in increased expression of DDX39B mRNA CTD PMID:24136188 NCBI chr20:4,806,103...4,818,600
Ensembl chr20:4,806,108...4,818,568
JBrowse link
G Ddx49 DEAD-box helicase 49 increases expression EXP Glafenine results in increased expression of DDX49 mRNA CTD PMID:24136188 NCBI chr16:20,873,585...20,881,312
Ensembl chr16:20,873,642...20,881,439
JBrowse link
G Decr2 2,4-dienoyl-CoA reductase 2 decreases expression EXP Glafenine results in decreased expression of DECR2 mRNA CTD PMID:24136188 NCBI chr10:15,451,850...15,460,227
Ensembl chr10:15,431,638...15,465,413
JBrowse link
G Dek DEK proto-oncogene decreases expression EXP Glafenine results in decreased expression of DEK mRNA CTD PMID:24136188 NCBI chr17:17,965,872...17,987,836
Ensembl chr17:17,965,881...17,987,834
JBrowse link
G Dennd6a DENN domain containing 6A decreases expression EXP Glafenine results in decreased expression of DENND6A mRNA CTD PMID:24136188 NCBI chr16:2,278,701...2,327,062
Ensembl chr16:2,278,701...2,327,062
JBrowse link
G Depdc7 DEP domain containing 7 decreases expression EXP Glafenine results in decreased expression of DEPDC7 mRNA CTD PMID:24136188 NCBI chr 3:94,665,714...94,687,013
Ensembl chr 3:94,665,717...94,686,989
JBrowse link
G Dera deoxyribose-phosphate aldolase decreases expression EXP Glafenine results in decreased expression of DERA mRNA CTD PMID:24136188 NCBI chr 4:171,748,254...171,826,414
Ensembl chr 4:171,748,273...171,826,409
JBrowse link
G Derl1 derlin 1 increases expression EXP Glafenine results in increased expression of DERL1 mRNA CTD PMID:24136188 NCBI chr 7:97,737,176...97,759,852
Ensembl chr 7:97,737,178...97,759,852
JBrowse link
G Desi2 desumoylating isopeptidase 2 increases expression EXP Glafenine results in increased expression of DESI2 mRNA CTD PMID:24136188 NCBI chr13:96,111,800...96,156,693
Ensembl chr13:96,111,800...96,154,685
JBrowse link
G Dhcr24 24-dehydrocholesterol reductase increases expression EXP Glafenine results in increased expression of DHCR24 mRNA CTD PMID:24136188 NCBI chr 5:126,164,708...126,188,926
Ensembl chr 5:126,164,674...126,191,206
JBrowse link
G Dhodh dihydroorotate dehydrogenase (quinone) increases expression EXP Glafenine results in increased expression of DHODH mRNA CTD PMID:24136188 NCBI chr19:42,066,103...42,087,906
Ensembl chr19:42,066,351...42,082,012
JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression EXP Glafenine results in decreased expression of DHRS3 mRNA CTD PMID:24136188 NCBI chr 5:162,809,090...162,843,385
Ensembl chr 5:162,808,646...162,843,383
JBrowse link
G Dhrs7b dehydrogenase/reductase 7B increases expression EXP Glafenine results in increased expression of DHRS7B mRNA CTD PMID:24136188 NCBI chr10:47,065,755...47,111,089
Ensembl chr10:47,065,850...47,111,101
JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 decreases expression EXP Glafenine results in decreased expression of DHTKD1 mRNA CTD PMID:24136188 NCBI chr17:76,306,585...76,358,058
Ensembl chr17:76,306,585...76,358,058
JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression EXP Glafenine results in increased expression of DMBT1 mRNA CTD PMID:24136188 NCBI chr 1:201,620,642...201,689,905
NCBI chr 1:203,149,414...203,228,705
JBrowse link
G Dmgdh dimethylglycine dehydrogenase decreases expression EXP Glafenine results in decreased expression of DMGDH mRNA CTD PMID:24136188 NCBI chr 2:23,289,376...23,370,360
Ensembl chr 2:23,289,374...23,370,477
JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 increases expression EXP Glafenine results in increased expression of DNAJB11 mRNA CTD PMID:24136188 NCBI chr11:81,741,342...81,757,806
Ensembl chr11:81,741,297...81,757,813
JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression EXP Glafenine results in increased expression of DNAJB9 mRNA CTD PMID:24136188 NCBI chr 6:64,165,913...64,170,122
Ensembl chr 6:64,165,913...64,170,151
JBrowse link
G Dnajc15 DnaJ heat shock protein family (Hsp40) member C15 increases expression EXP Glafenine results in increased expression of DNAJC15 mRNA CTD PMID:24136188 NCBI chr15:59,990,131...60,056,710
Ensembl chr15:59,990,131...60,056,710
JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 increases expression EXP Glafenine results in increased expression of DNAJC3 mRNA CTD PMID:24136188 NCBI chr15:104,186,918...104,226,236
Ensembl chr15:104,186,792...104,226,329
JBrowse link
G Dnlz DNL-type zinc finger increases expression EXP Glafenine results in increased expression of DNLZ mRNA CTD PMID:24136188 NCBI chr 3:3,796,480...3,798,467
Ensembl chr 3:3,796,480...3,798,239
JBrowse link
G Dock9 dedicator of cytokinesis 9 decreases expression EXP Glafenine results in decreased expression of DOCK9 mRNA CTD PMID:24136188 NCBI chr15:107,945,664...108,210,967
Ensembl chr15:107,945,664...108,210,826
JBrowse link
G Dpagt1 dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 increases expression EXP Glafenine results in increased expression of DPAGT1 mRNA CTD PMID:24136188 NCBI chr 8:48,657,779...48,664,531
Ensembl chr 8:48,657,795...48,664,860
JBrowse link
G Dph1 diphthamide biosynthesis 1 increases expression EXP Glafenine results in increased expression of DPH1 mRNA CTD PMID:24136188 NCBI chr10:62,019,379...62,032,384
Ensembl chr10:62,019,379...62,032,407
JBrowse link
G Dph3 diphthamide biosynthesis 3 increases expression EXP Glafenine results in increased expression of DPH3 mRNA CTD PMID:24136188 NCBI chr16:8,202,048...8,207,492
Ensembl chr16:8,202,048...8,207,464
JBrowse link
G Dph5 diphthamide biosynthesis 5 increases expression EXP Glafenine results in increased expression of DPH5 mRNA CTD PMID:24136188 NCBI chr 2:218,834,034...218,866,763
Ensembl chr 2:218,834,034...218,866,761
JBrowse link
G Dpm3 dolichyl-phosphate mannosyltransferase subunit 3, regulatory increases expression EXP Glafenine results in increased expression of DPM3 mRNA CTD PMID:24136188 NCBI chr 2:188,583,664...188,584,179
Ensembl chr 2:188,583,664...188,584,179
JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression EXP Glafenine results in decreased expression of DPP4 mRNA CTD PMID:24136188 NCBI chr 3:48,291,055...48,372,672
Ensembl chr 3:48,291,055...48,372,672
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase decreases expression EXP Glafenine results in decreased expression of DPYD mRNA CTD PMID:24136188 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
JBrowse link
G Dpys dihydropyrimidinase decreases expression EXP Glafenine results in decreased expression of DPYS mRNA CTD PMID:24136188 NCBI chr 7:78,769,918...78,847,941
Ensembl chr 7:78,769,807...78,847,974
JBrowse link
G Dram2 DNA-damage regulated autophagy modulator 2 decreases expression EXP Glafenine results in decreased expression of DRAM2 mRNA CTD PMID:24136188 NCBI chr 2:209,160,901...209,189,641
Ensembl chr 2:209,161,047...209,188,622
JBrowse link
G Drap1 Dr1 associated protein 1 increases expression EXP Glafenine results in increased expression of DRAP1 mRNA CTD PMID:24136188 NCBI chr 1:220,803,783...220,806,480
Ensembl chr 1:220,803,796...220,806,433
JBrowse link
G Dsc2 desmocollin 2 increases expression EXP Glafenine results in increased expression of DSC2 mRNA CTD PMID:24136188 NCBI chr18:11,826,705...11,858,801
Ensembl chr18:11,826,706...11,858,754
JBrowse link
G Dsp desmoplakin decreases expression EXP Glafenine results in decreased expression of DSP mRNA CTD PMID:24136188 NCBI chr17:27,286,811...27,334,453
Ensembl chr17:27,286,796...27,334,379
JBrowse link
G Dusp11 dual specificity phosphatase 11 increases expression EXP Glafenine results in increased expression of DUSP11 mRNA CTD PMID:24136188 NCBI chr 4:117,617,640...117,631,674
Ensembl chr 4:117,617,533...117,631,716
JBrowse link
G Dynll1 dynein light chain LC8-type 1 increases expression EXP Glafenine results in increased expression of DYNLL1 mRNA CTD PMID:24136188 NCBI chr12:47,074,200...47,076,573
Ensembl chr12:47,074,200...47,076,572
JBrowse link
G Dynlt1 dynein light chain Tctex-type 1 increases expression EXP Glafenine results in increased expression of DYNLT1 mRNA CTD PMID:24136188 NCBI chr 1:47,206,892...47,213,785
Ensembl chr 1:47,206,895...47,213,749
JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 decreases expression EXP Glafenine results in decreased expression of DYNLT3 mRNA CTD PMID:24136188 NCBI chr  X:14,633,342...14,642,356
Ensembl chr  X:14,633,342...14,642,424
JBrowse link
G Dyrk2 dual specificity tyrosine phosphorylation regulated kinase 2 decreases expression EXP Glafenine results in decreased expression of DYRK2 mRNA CTD PMID:24136188 NCBI chr 7:61,785,423...61,816,775
Ensembl chr 7:61,786,309...61,798,729
JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 increases expression EXP Glafenine results in increased expression of EBNA1BP2 mRNA CTD PMID:24136188 NCBI chr 5:137,458,692...137,463,255
Ensembl chr 5:137,670,123...137,674,802
JBrowse link
G Echdc3 enoyl CoA hydratase domain containing 3 decreases expression EXP Glafenine results in decreased expression of ECHDC3 mRNA CTD PMID:24136188 NCBI chr17:76,002,304...76,022,813
Ensembl chr17:76,002,275...76,022,813
JBrowse link
G Eci2 enoyl-CoA delta isomerase 2 decreases expression EXP Glafenine results in decreased expression of ECI2 mRNA CTD PMID:24136188 NCBI chr17:30,556,926...30,573,324
Ensembl chr17:30,556,884...30,639,040
JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 increases expression EXP Glafenine results in increased expression of EDEM1 mRNA CTD PMID:24136188 NCBI chr 4:140,886,644...140,918,654
Ensembl chr 4:140,886,545...140,915,779
JBrowse link
G Edem2 ER degradation enhancing alpha-mannosidase like protein 2 increases expression EXP Glafenine results in increased expression of EDEM2 mRNA CTD PMID:24136188 NCBI chr 3:151,232,741...151,258,559
Ensembl chr 3:151,232,751...151,258,580
JBrowse link
G Eef1b2 eukaryotic translation elongation factor 1 beta 2 increases expression EXP Glafenine results in increased expression of EEF1B2 mRNA CTD PMID:24136188 NCBI chr 9:69,953,440...69,956,158
Ensembl chr 9:69,953,440...69,956,160
JBrowse link
G Eef1g eukaryotic translation elongation factor 1 gamma increases expression EXP Glafenine results in increased expression of EEF1G mRNA CTD PMID:24136188 NCBI chr 1:225,163,391...225,173,997
Ensembl chr 1:225,163,391...225,173,995
JBrowse link
G Eepd1 endonuclease/exonuclease/phosphatase family domain containing 1 decreases expression EXP Glafenine results in decreased expression of EEPD1 mRNA CTD PMID:24136188 NCBI chr 8:26,651,241...26,758,330
Ensembl chr 8:26,652,121...26,758,325
JBrowse link
G Efr3a EFR3 homolog A decreases expression EXP Glafenine results in decreased expression of EFR3A mRNA CTD PMID:24136188 NCBI chr 7:106,535,428...106,616,805
Ensembl chr 7:106,535,434...106,616,805
JBrowse link
G Egf epidermal growth factor decreases expression EXP Glafenine results in decreased expression of EGF mRNA CTD PMID:24136188 NCBI chr 2:68,820,616...68,895,537 JBrowse link
G Egfl7 EGF-like-domain, multiple 7 increases expression EXP Glafenine results in increased expression of EGFL7 mRNA CTD PMID:24136188 NCBI chr 3:4,034,759...4,044,280
Ensembl chr 3:4,034,921...4,043,936
JBrowse link
G Egfr epidermal growth factor receptor decreases expression EXP Glafenine results in decreased expression of EGFR mRNA CTD PMID:24136188 NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase decreases expression EXP Glafenine results in decreased expression of EHHADH mRNA CTD PMID:24136188 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364
JBrowse link
G Ei24 EI24, autophagy associated transmembrane protein decreases expression EXP Glafenine results in decreased expression of EI24 mRNA CTD PMID:24136188 NCBI chr 8:39,254,883...39,271,238
Ensembl chr 8:39,254,889...39,266,959
JBrowse link
G Eif1ad eukaryotic translation initiation factor 1A domain containing increases expression EXP Glafenine results in increased expression of EIF1AD mRNA CTD PMID:24136188 NCBI chr 1:220,746,387...220,751,687
Ensembl chr 1:220,746,387...220,751,684
JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 decreases expression EXP Glafenine results in decreased expression of EIF2AK1 mRNA CTD PMID:24136188 NCBI chr12:12,749,026...12,782,078
Ensembl chr12:12,748,785...12,782,146
JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases expression EXP Glafenine results in increased expression of EIF2S1 mRNA CTD PMID:24136188 NCBI chr 6:102,048,372...102,073,041
Ensembl chr 6:102,048,372...102,073,041
JBrowse link
G Eif2s3 eukaryotic translation initiation factor 2 subunit gamma decreases expression EXP Glafenine results in decreased expression of EIF2S3X mRNA CTD PMID:24136188 NCBI chr  X:63,268,106...63,291,125
Ensembl chr  X:63,268,037...63,292,092
JBrowse link
G Eif3b eukaryotic translation initiation factor 3, subunit B increases expression EXP Glafenine results in increased expression of EIF3B mRNA CTD PMID:24136188 NCBI chr12:16,285,730...16,310,190
Ensembl chr12:16,285,733...16,310,190
JBrowse link
G Eif3i eukaryotic translation initiation factor 3, subunit I increases expression EXP Glafenine results in increased expression of EIF3I mRNA CTD PMID:24136188 NCBI chr 5:147,796,580...147,803,853
Ensembl chr 5:147,796,662...147,803,851
JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases expression EXP Glafenine results in increased expression of EIF4A1 mRNA CTD PMID:24136188 NCBI chr10:56,271,257...56,276,764
Ensembl chr10:56,271,257...56,276,764
JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 decreases expression EXP Glafenine results in decreased expression of EIF4A2 mRNA CTD PMID:24136188 NCBI chr11:81,373,047...81,379,680
Ensembl chr11:81,373,048...81,379,871
JBrowse link
G Eif4b eukaryotic translation initiation factor 4B decreases expression EXP Glafenine results in decreased expression of EIF4B mRNA CTD PMID:24136188 NCBI chr 7:143,679,656...143,701,452
Ensembl chr 7:143,679,617...143,701,452
JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma, 1 increases expression EXP Glafenine results in increased expression of EIF4G1 mRNA CTD PMID:24136188 NCBI chr11:83,907,659...83,927,683
Ensembl chr11:83,908,109...83,926,524
JBrowse link
G Eif5a eukaryotic translation initiation factor 5A increases expression EXP Glafenine results in increased expression of EIF5A mRNA CTD PMID:24136188 NCBI chr10:56,527,075...56,531,615
Ensembl chr10:56,527,085...56,531,483
JBrowse link
G Eif6 eukaryotic translation initiation factor 6 increases expression EXP Glafenine results in increased expression of EIF6 mRNA CTD PMID:24136188 NCBI chr 3:151,356,867...151,363,201
Ensembl chr 3:151,356,868...151,363,115
JBrowse link
G Eipr1 EARP complex and GARP complex interacting protein 1 increases expression EXP Glafenine results in increased expression of EIPR1 mRNA CTD PMID:24136188 NCBI chr 6:48,021,771...48,135,241
Ensembl chr 6:48,021,771...48,135,241
JBrowse link
G Ell3 elongation factor for RNA polymerase II 3 increases expression EXP Glafenine results in increased expression of ELL3 mRNA CTD PMID:24136188 NCBI chr 3:113,400,395...113,405,869
Ensembl chr 3:113,401,734...113,405,829
JBrowse link
G Elob elongin B increases expression EXP Glafenine results in increased expression of ELOB mRNA CTD PMID:24136188 NCBI chr10:13,163,032...13,168,217
Ensembl chr10:13,163,036...13,168,217
JBrowse link
G Elof1 elongation factor 1 homolog increases expression EXP Glafenine results in increased expression of ELOF1 mRNA CTD PMID:24136188 NCBI chr 8:23,125,987...23,130,980
Ensembl chr 8:23,125,988...23,130,877
JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression EXP Glafenine results in increased expression of ELOVL6 mRNA CTD PMID:24136188 NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145
Ensembl chr 2:234,189,105...234,296,145
JBrowse link
G Emc6 ER membrane protein complex subunit 6 increases expression EXP Glafenine results in increased expression of EMC6 mRNA CTD PMID:24136188 NCBI chr10:59,741,772...59,743,338
Ensembl chr10:59,741,772...59,743,315
JBrowse link
G Emilin1 elastin microfibril interfacer 1 increases expression EXP Glafenine results in increased expression of EMILIN1 mRNA CTD PMID:24136188 NCBI chr 6:26,821,249...26,829,013
Ensembl chr 6:26,821,255...26,828,972
JBrowse link
G Enc1 ectodermal-neural cortex 1 increases expression EXP Glafenine results in increased expression of ENC1 mRNA CTD PMID:24136188 NCBI chr 2:28,049,217...28,061,023
Ensembl chr 2:28,049,217...28,061,029
JBrowse link
G Eng endoglin increases expression EXP Glafenine results in increased expression of ENG mRNA CTD PMID:24136188 NCBI chr 3:11,679,530...11,717,486
Ensembl chr 3:11,679,530...11,717,485
JBrowse link
G Enpep glutamyl aminopeptidase decreases expression EXP Glafenine results in decreased expression of ENPEP mRNA CTD PMID:24136188 NCBI chr 2:233,667,253...233,743,866
Ensembl chr 2:233,667,254...233,743,866
JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression EXP Glafenine results in decreased expression of ENPP2 mRNA CTD PMID:24136188 NCBI chr 7:94,479,931...94,563,086
Ensembl chr 7:94,480,396...94,563,001
JBrowse link
G Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 decreases expression EXP Glafenine results in decreased expression of ENPP3 mRNA CTD PMID:24136188 NCBI chr 1:21,613,148...21,684,483
Ensembl chr 1:21,613,148...21,684,480
JBrowse link
G Eola2 endothelium and lymphocyte associated ASCH domain 2 increases expression EXP Glafenine results in increased expression of EOLA2 mRNA CTD PMID:24136188 NCBI chr 8:69,484,134...69,488,998
Ensembl chr 8:69,484,174...69,489,891
JBrowse link
G Ephx1 epoxide hydrolase 1 decreases expression EXP Glafenine results in decreased expression of EPHX1 mRNA CTD PMID:24136188 NCBI chr13:99,271,390...99,300,580
Ensembl chr13:99,271,366...99,300,579
JBrowse link
G Eprs glutamyl-prolyl-tRNA synthetase increases expression EXP Glafenine results in increased expression of EPRS mRNA CTD PMID:24136188 NCBI chr13:103,300,911...103,371,651
Ensembl chr13:103,300,932...103,371,577
JBrowse link
G Eps8l2 EPS8-like 2 decreases expression EXP Glafenine results in decreased expression of EPS8L2 mRNA CTD PMID:24136188 NCBI chr 1:214,327,992...214,353,466
Ensembl chr 1:214,328,071...214,353,461
JBrowse link
G Erg28 ergosterol biosynthesis 28 homolog increases expression EXP Glafenine results in increased expression of ERG28 mRNA CTD PMID:24136188 NCBI chr 6:109,683,252...109,692,218
Ensembl chr 6:109,683,253...109,692,218
JBrowse link
G Erh ERH, mRNA splicing and mitosis factor increases expression EXP Glafenine results in increased expression of ERH mRNA CTD PMID:24136188 NCBI chr 6:104,280,390...104,290,905
Ensembl chr 6:104,280,408...104,290,579
JBrowse link
G Erp29 endoplasmic reticulum protein 29 increases expression EXP Glafenine results in increased expression of ERP29 mRNA CTD PMID:24136188 NCBI chr12:40,619,377...40,625,884
Ensembl chr12:40,619,377...40,625,883
JBrowse link
G Erp44 endoplasmic reticulum protein 44 increases expression EXP Glafenine results in increased expression of ERP44 mRNA CTD PMID:24136188 NCBI chr 5:63,937,866...64,030,827
Ensembl chr 5:63,937,784...64,030,901
JBrowse link
G Esam endothelial cell adhesion molecule increases expression EXP Glafenine results in increased expression of ESAM mRNA CTD PMID:24136188 NCBI chr 8:39,997,875...40,008,802
Ensembl chr 8:39,997,875...40,008,809
JBrowse link
G Etfdh electron transfer flavoprotein dehydrogenase decreases expression EXP Glafenine results in decreased expression of ETFDH mRNA CTD PMID:24136188 NCBI chr 2:178,367,547...178,389,641
Ensembl chr 2:178,367,549...178,389,608
JBrowse link
G Ethe1 ETHE1, persulfide dioxygenase decreases expression EXP Glafenine results in decreased expression of ETHE1 mRNA CTD PMID:24136188 NCBI chr 1:81,457,008...81,472,061
Ensembl chr 1:81,456,984...81,472,097
JBrowse link
G Faah fatty acid amide hydrolase decreases expression EXP Glafenine results in decreased expression of FAAH mRNA CTD PMID:24136188 NCBI chr 5:134,852,899...134,872,095
Ensembl chr 5:134,852,875...134,871,775
JBrowse link
G Fabp4 fatty acid binding protein 4 increases expression EXP Glafenine results in increased expression of FABP4 mRNA CTD PMID:24136188 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
JBrowse link
G Fabp5 fatty acid binding protein 5 increases expression EXP Glafenine results in increased expression of FABP5 mRNA CTD PMID:24136188 NCBI chr 2:93,981,662...93,985,322
Ensembl chr 2:93,981,656...93,985,378
JBrowse link
G Fads1 fatty acid desaturase 1 decreases expression EXP Glafenine results in decreased expression of FADS1 mRNA CTD PMID:24136188 NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
JBrowse link
G Fads2 fatty acid desaturase 2 decreases expression EXP Glafenine results in decreased expression of FADS2 mRNA CTD PMID:24136188 NCBI chr 1:225,906,582...226,152,568
Ensembl chr 1:226,114,413...226,152,524
JBrowse link
G Fam114a1 family with sequence similarity 114, member A1 increases expression EXP Glafenine results in increased expression of FAM114A1 mRNA CTD PMID:24136188 NCBI chr14:44,941,705...45,012,299
Ensembl chr14:44,943,172...45,002,719
JBrowse link
G Fam117b family with sequence similarity 117, member B decreases expression EXP Glafenine results in decreased expression of FAM117B mRNA CTD PMID:24136188 NCBI chr 9:66,716,969...66,784,487
Ensembl chr 9:66,716,969...66,784,487
JBrowse link
G Fam167b family with sequence similarity 167, member B increases expression EXP Glafenine results in increased expression of FAM167B mRNA CTD PMID:24136188 NCBI chr 5:147,782,692...147,784,345
Ensembl chr 5:147,782,694...147,784,311
JBrowse link
G Fam210a family with sequence similarity 210, member A decreases expression EXP Glafenine results in decreased expression of FAM210A mRNA CTD PMID:24136188 NCBI chr18:64,045,023...64,084,594
Ensembl chr18:64,045,432...64,084,556
JBrowse link
G Fam210b family with sequence similarity 210, member B decreases expression EXP Glafenine results in decreased expression of FAM210B mRNA CTD PMID:24136188 NCBI chr 3:170,354,109...170,364,265
Ensembl chr 3:170,354,141...170,362,513
JBrowse link
G Fam214a family with sequence similarity 214, member A decreases expression EXP Glafenine results in decreased expression of FAM214A mRNA CTD PMID:24136188 NCBI chr 8:81,863,619...81,941,548
Ensembl chr 8:81,863,619...81,941,536
JBrowse link
G Fam241b family with sequence similarity 241 member B decreases expression EXP Glafenine results in decreased expression of FAM241B mRNA CTD PMID:24136188 NCBI chr20:31,734,297...31,736,115
Ensembl chr20:31,734,183...31,736,212
JBrowse link
G Fam3c FAM3 metabolism regulating signaling molecule C increases expression EXP Glafenine results in increased expression of FAM3C mRNA CTD PMID:24136188 NCBI chr 4:49,388,962...49,439,892
Ensembl chr 4:49,387,989...49,439,867
JBrowse link
G Farsb phenylalanyl-tRNA synthetase subunit beta increases expression EXP Glafenine results in increased expression of FARSB mRNA CTD PMID:24136188 NCBI chr 9:84,324,456...84,383,674
Ensembl chr 9:84,324,442...84,383,687
JBrowse link
G Fasn fatty acid synthase increases expression EXP Glafenine results in increased expression of FASN mRNA CTD PMID:24136188 NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
JBrowse link
G Fastk Fas-activated serine/threonine kinase increases expression EXP Glafenine results in increased expression of FASTK mRNA CTD PMID:24136188 NCBI chr 4:7,260,521...7,264,590
Ensembl chr 4:7,260,575...7,264,589
JBrowse link
G Fbl fibrillarin increases expression EXP Glafenine results in increased expression of FBL mRNA CTD PMID:24136188 NCBI chr 1:85,103,519...85,112,619
Ensembl chr 1:85,103,519...85,112,619
JBrowse link
G Fbxo3 F-box protein 3 decreases expression EXP Glafenine results in decreased expression of FBXO3 mRNA CTD PMID:24136188 NCBI chr 3:93,968,827...94,000,863
Ensembl chr 3:93,968,855...94,000,863
JBrowse link
G Fbxo7 F-box protein 7 decreases expression EXP Glafenine results in decreased expression of FBXO7 mRNA CTD PMID:24136188 NCBI chr 7:23,815,246...23,843,505
Ensembl chr 7:23,815,245...23,843,634
JBrowse link
G Fcgr2b Fc fragment of IgG receptor IIb increases expression EXP Glafenine results in increased expression of FCGR2B mRNA CTD PMID:24136188 NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815
JBrowse link
G Fchsd2 FCH and double SH3 domains 2 decreases expression EXP Glafenine results in decreased expression of FCHSD2 mRNA CTD PMID:24136188 NCBI chr 1:166,140,025...166,395,915
Ensembl chr 1:166,125,474...166,395,915
JBrowse link
G Fdps farnesyl diphosphate synthase increases expression EXP Glafenine results in increased expression of FDPS mRNA CTD PMID:24136188 NCBI chr 2:188,403,595...188,413,219
Ensembl chr 2:188,392,858...188,413,219
JBrowse link
G Fdx1 ferredoxin 1 decreases expression EXP Glafenine results in decreased expression of FDX1 mRNA CTD PMID:24136188 NCBI chr 8:56,373,729...56,393,199
Ensembl chr 8:56,373,723...56,393,233
JBrowse link
G Fdxr ferredoxin reductase decreases expression EXP Glafenine results in decreased expression of FDXR mRNA CTD PMID:24136188 NCBI chr10:103,817,724...103,826,413
Ensembl chr10:103,817,704...103,826,448
JBrowse link
G Fech ferrochelatase decreases expression EXP Glafenine results in decreased expression of FECH mRNA CTD PMID:24136188 NCBI chr18:59,941,992...59,975,192
Ensembl chr18:59,941,992...59,975,192
JBrowse link
G Fermt2 fermitin family member 2 decreases expression EXP Glafenine results in decreased expression of FERMT2 mRNA CTD PMID:24136188 NCBI chr15:19,807,806...19,876,557
Ensembl chr15:19,807,808...19,876,408
JBrowse link
G Fga fibrinogen alpha chain increases expression EXP Glafenine results in increased expression of FGA mRNA CTD PMID:24136188 NCBI chr 2:181,997,562...182,013,726
Ensembl chr 2:182,006,242...182,013,763
JBrowse link
G Fgl1 fibrinogen-like 1 increases expression EXP Glafenine results in increased expression of FGL1 mRNA CTD PMID:24136188 NCBI chr16:54,153,086...54,188,120
Ensembl chr16:54,153,054...54,188,181
JBrowse link
G Fis1 fission, mitochondrial 1 increases expression EXP Glafenine results in increased expression of FIS1 mRNA CTD PMID:24136188 NCBI chr12:22,750,485...22,765,324
Ensembl chr12:22,750,485...22,765,308
JBrowse link
G Fitm2 fat storage-inducing transmembrane protein 2 decreases expression EXP Glafenine results in decreased expression of FITM2 mRNA CTD PMID:24136188 NCBI chr 3:159,856,994...159,863,506
Ensembl chr 3:159,856,994...159,863,506
JBrowse link
G Fkbp11 FKBP prolyl isomerase 11 increases expression EXP Glafenine results in increased expression of FKBP11 mRNA CTD PMID:24136188 NCBI chr 7:140,398,253...140,402,664
Ensembl chr 7:140,398,199...140,437,467
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 increases expression EXP Glafenine results in increased expression of FKBP5 mRNA CTD PMID:24136188 NCBI chr20:7,976,704...8,097,290
Ensembl chr20:7,976,713...8,019,020
JBrowse link
G Flad1 flavin adenine dinucleotide synthetase 1 increases expression EXP Glafenine results in increased expression of FLAD1 mRNA CTD PMID:24136188 NCBI chr 2:188,726,994...188,736,462
Ensembl chr 2:188,726,994...188,736,462
JBrowse link
G Flcn folliculin decreases expression EXP Glafenine results in decreased expression of FLCN mRNA CTD PMID:24136188 NCBI chr10:46,153,185...46,172,331
Ensembl chr10:46,153,188...46,172,309
JBrowse link
G Flna filamin A increases expression EXP Glafenine results in increased expression of FLNA mRNA CTD PMID:24136188 NCBI chr  X:156,460,785...156,487,245
Ensembl chr  X:156,463,953...156,487,245
JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 decreases expression EXP Glafenine results in decreased expression of FMO1 mRNA CTD PMID:24136188 NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 decreases expression EXP Glafenine results in decreased expression of FMO3 mRNA CTD PMID:24136188 NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963
JBrowse link
G Fn1 fibronectin 1 increases expression EXP Glafenine results in increased expression of FN1 mRNA CTD PMID:24136188 NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
JBrowse link
G Fn3krp fructosamine-3-kinase-related protein decreases expression EXP Glafenine results in decreased expression of FN3KRP mRNA CTD PMID:24136188 NCBI chr10:110,614,739...110,622,625
Ensembl chr10:110,614,713...110,623,519
JBrowse link
G Fndc3b fibronectin type III domain containing 3B increases expression EXP Glafenine results in increased expression of FNDC3B mRNA CTD PMID:24136188 NCBI chr 2:113,109,949...113,415,171
Ensembl chr 2:113,112,902...113,345,577
JBrowse link
G Foxa2 forkhead box A2 decreases expression EXP Glafenine results in decreased expression of FOXA2 mRNA CTD PMID:24136188 NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
JBrowse link
G Foxa3 forkhead box A3 increases expression EXP Glafenine results in increased expression of FOXA3 mRNA CTD PMID:24136188 NCBI chr 1:79,921,292...79,930,219
Ensembl chr 1:79,920,752...79,930,263
JBrowse link
G Foxn3 forkhead box N3 decreases expression EXP Glafenine results in decreased expression of FOXN3 mRNA CTD PMID:24136188 NCBI chr 6:123,183,720...123,577,719
Ensembl chr 6:123,187,726...123,577,695
JBrowse link
G Fpgs folylpolyglutamate synthase increases expression EXP Glafenine results in increased expression of FPGS mRNA CTD PMID:24136188 NCBI chr 3:11,717,667...11,729,694
Ensembl chr 3:11,717,667...11,723,327
JBrowse link
G Ftcd formimidoyltransferase cyclodeaminase decreases expression EXP Glafenine results in decreased expression of FTCD mRNA CTD PMID:24136188 NCBI chr20:12,806,957...12,820,466
Ensembl chr20:12,806,957...12,820,466
JBrowse link
G Ftsj3 FtsJ RNA 2'-O-methyltransferase 3 increases expression EXP Glafenine results in increased expression of FTSJ3 mRNA CTD PMID:24136188 NCBI chr10:94,439,059...94,445,503
Ensembl chr10:94,439,077...94,445,503
JBrowse link
G Fuca2 alpha-L-fucosidase 2 decreases expression EXP Glafenine results in decreased expression of FUCA2 mRNA CTD PMID:24136188 NCBI chr 1:7,658,919...7,673,663
Ensembl chr 1:7,658,890...7,673,683
JBrowse link
G Fundc2 FUN14 domain containing 2 increases expression EXP Glafenine results in increased expression of FUNDC2 mRNA CTD PMID:24136188 NCBI chr18:401,878...407,954
Ensembl chr18:402,295...407,954
JBrowse link
G Fus FUS RNA binding protein increases expression EXP Glafenine results in increased expression of FUS mRNA CTD PMID:24136188 NCBI chr 1:199,412,805...199,426,705
Ensembl chr 1:199,412,834...199,426,702
JBrowse link
G Fut8 fucosyltransferase 8 increases expression EXP Glafenine results in increased expression of FUT8 mRNA CTD PMID:24136188 NCBI chr 6:100,305,957...100,537,208
Ensembl chr 6:100,337,226...100,537,224
JBrowse link
G Fxr1 FMR1 autosomal homolog 1 decreases expression EXP Glafenine results in decreased expression of FXR1 mRNA CTD PMID:24136188 NCBI chr 2:120,529,716...120,570,356
Ensembl chr 2:120,512,899...120,570,355
JBrowse link
G Fyco1 FYVE and coiled-coil domain autophagy adaptor 1 decreases expression EXP Glafenine results in decreased expression of FYCO1 mRNA CTD PMID:24136188 NCBI chr 8:132,844,042...132,910,905
Ensembl chr 8:132,844,043...132,911,193
JBrowse link
G Fzd8 frizzled class receptor 8 decreases expression EXP Glafenine results in decreased expression of FZD8 mRNA CTD PMID:24136188 NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113
JBrowse link
G G6pc glucose-6-phosphatase, catalytic subunit decreases expression EXP Glafenine results in decreased expression of G6PC mRNA CTD PMID:24136188 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression EXP Glafenine results in increased expression of G6PD mRNA CTD PMID:24136188 NCBI chr  X:156,274,800...156,293,935
Ensembl chr  X:156,274,800...156,293,926
JBrowse link
G Gab1 GRB2-associated binding protein 1 decreases expression EXP Glafenine results in decreased expression of GAB1 mRNA CTD PMID:24136188 NCBI chr19:30,794,290...30,903,819
Ensembl chr19:30,794,571...30,902,008
JBrowse link
G Gabarapl1 GABA type A receptor associated protein like 1 decreases expression EXP Glafenine results in decreased expression of GABARAPL1 mRNA CTD PMID:24136188 NCBI chr 4:163,293,724...163,302,866
Ensembl chr 4:163,293,724...163,302,858
JBrowse link
G Gabarapl2 GABA type A receptor associated protein like 2 decreases expression EXP Glafenine results in decreased expression of GABARAPL2 mRNA CTD PMID:24136188 NCBI chr19:44,164,935...44,175,771
Ensembl chr19:44,164,935...44,175,770
JBrowse link
G Gale UDP-galactose-4-epimerase increases expression EXP Glafenine results in increased expression of GALE mRNA CTD PMID:24136188 NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955
JBrowse link
G Galk2 galactokinase 2 decreases expression EXP Glafenine results in decreased expression of GALK2 mRNA CTD PMID:24136188 NCBI chr 3:118,137,097...118,268,838
Ensembl chr 3:118,136,838...118,268,836
JBrowse link
G Galm galactose mutarotase decreases expression EXP Glafenine results in decreased expression of GALM mRNA CTD PMID:24136188 NCBI chr 6:2,808,988...2,860,742
Ensembl chr 6:2,808,841...2,860,744
JBrowse link
G Galnt11 polypeptide N-acetylgalactosaminyltransferase 11 decreases expression EXP Glafenine results in decreased expression of GALNT11 mRNA CTD PMID:24136188 NCBI chr 4:6,297,255...6,330,765
Ensembl chr 4:6,297,258...6,330,765
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression EXP Glafenine results in increased expression of GAPDH mRNA CTD PMID:24136188 NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
JBrowse link
G Gar1 GAR1 ribonucleoprotein increases expression EXP Glafenine results in increased expression of GAR1 mRNA CTD PMID:24136188 NCBI chr 2:235,250,453...235,258,464
Ensembl chr 2:235,250,453...235,257,731
JBrowse link
G Gas5 growth arrest specific 5 increases expression EXP Glafenine results in increased expression of GAS5 mRNA CTD PMID:24136188 NCBI chr13:78,852,523...78,855,844 JBrowse link
G Gas6 growth arrest specific 6 increases expression EXP Glafenine results in increased expression of GAS6 mRNA CTD PMID:24136188 NCBI chr16:81,213,364...81,243,824
Ensembl chr16:81,213,364...81,243,757
JBrowse link
G Gbe1 1,4-alpha-glucan branching enzyme 1 decreases expression EXP Glafenine results in decreased expression of GBE1 mRNA CTD PMID:24136188 NCBI chr11:7,210,169...7,485,895
Ensembl chr11:7,210,209...7,485,890
JBrowse link
G Gcdh glutaryl-CoA dehydrogenase decreases expression EXP Glafenine results in decreased expression of GCDH mRNA CTD PMID:24136188 NCBI chr19:26,000,497...26,006,970
Ensembl chr19:26,000,497...26,006,970
JBrowse link
G Gck glucokinase increases expression EXP Glafenine results in increased expression of GCK mRNA CTD PMID:24136188 NCBI chr14:86,149,146...86,191,589
Ensembl chr14:86,148,928...86,190,659
JBrowse link
G Gckr glucokinase regulator decreases expression EXP Glafenine results in decreased expression of GCKR mRNA CTD PMID:24136188 NCBI chr 6:26,355,296...26,385,761
Ensembl chr 6:26,355,296...26,385,761
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit decreases expression EXP Glafenine results in decreased expression of GCLM mRNA CTD PMID:24136188 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
JBrowse link
G Gcnt2 glucosaminyl (N-acetyl) transferase 2 (I blood group) increases expression EXP Glafenine results in increased expression of GCNT2 mRNA CTD PMID:24136188 NCBI chr17:21,634,546...21,677,477
Ensembl chr17:21,634,551...21,739,408
JBrowse link
G Gda guanine deaminase increases expression EXP Glafenine results in increased expression of GDA mRNA CTD PMID:24136188 NCBI chr 1:238,982,542...239,057,663
Ensembl chr 1:238,982,392...239,057,732
JBrowse link
G Get4 guided entry of tail-anchored proteins factor 4 increases expression EXP Glafenine results in increased expression of GET4 mRNA CTD PMID:24136188 NCBI chr12:17,469,112...17,486,709
Ensembl chr12:17,469,112...17,486,157
JBrowse link
G Gga2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 decreases expression EXP Glafenine results in decreased expression of GGA2 mRNA CTD PMID:24136188 NCBI chr 1:191,951,578...191,984,858
Ensembl chr 1:191,951,581...191,984,858
JBrowse link
G Ggct gamma-glutamyl cyclotransferase increases expression EXP Glafenine results in increased expression of GGCT mRNA CTD PMID:24136188 NCBI chr 4:85,186,644...85,192,857
Ensembl chr 4:85,186,644...85,192,834
JBrowse link
G Ggcx gamma-glutamyl carboxylase increases expression EXP Glafenine results in increased expression of GGCX mRNA CTD PMID:24136188 NCBI chr 4:100,277,345...100,293,097
Ensembl chr 4:100,277,391...100,293,250
JBrowse link
G Ghr growth hormone receptor decreases expression EXP Glafenine results in decreased expression of GHR mRNA CTD PMID:24136188 NCBI chr 2:53,149,225...53,413,954
Ensembl chr 2:53,150,370...53,413,638
JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression EXP Glafenine results in increased expression of GJA1 mRNA CTD PMID:24136188 NCBI chr20:37,876,650...37,889,097
Ensembl chr20:37,876,650...37,889,089
JBrowse link
G Gk glycerol kinase decreases expression EXP Glafenine results in decreased expression of GK mRNA CTD PMID:24136188 NCBI chr  X:54,227,291...54,303,897
Ensembl chr  X:54,227,397...54,303,864
JBrowse link
G Glb1 galactosidase, beta 1 decreases expression EXP Glafenine results in decreased expression of GLB1 mRNA CTD PMID:24136188 NCBI chr 8:122,439,328...122,511,939
Ensembl chr 8:122,439,328...122,511,939
JBrowse link
G Gls2 glutaminase 2 decreases expression EXP Glafenine results in decreased expression of GLS2 mRNA CTD PMID:24136188 NCBI chr 7:2,605,679...2,621,853
Ensembl chr 7:2,605,719...2,621,852
JBrowse link
G Glt8d1 glycosyltransferase 8 domain containing 1 increases expression EXP Glafenine results in increased expression of GLT8D1 mRNA CTD PMID:24136188 NCBI chr16:7,082,450...7,097,405
Ensembl chr16:7,082,450...7,097,401
JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression EXP Glafenine results in decreased expression of GLUD1 mRNA CTD PMID:24136188 NCBI chr16:10,661,486...10,695,557
Ensembl chr16:10,662,021...10,695,557
JBrowse link
G Glyat glycine-N-acyltransferase decreases expression EXP Glafenine results in decreased expression of GLYAT mRNA CTD PMID:24136188 NCBI chr 1:229,060,125...229,081,113
Ensembl chr 1:229,063,714...229,080,410
JBrowse link
G Glyr1 glyoxylate reductase 1 homolog decreases expression EXP Glafenine results in decreased expression of GLYR1 mRNA CTD PMID:24136188 NCBI chr10:10,725,830...10,759,471
Ensembl chr10:10,725,819...10,761,279
JBrowse link
G Gmcl1 germ cell-less 1, spermatogenesis associated decreases expression EXP Glafenine results in decreased expression of GMCL1 mRNA CTD PMID:24136188 NCBI chr 4:118,494,997...118,534,301
Ensembl chr 4:118,478,075...118,534,280
JBrowse link
G Gmfg glia maturation factor, gamma increases expression EXP Glafenine results in increased expression of GMFG mRNA CTD PMID:24136188 NCBI chr 1:85,312,473...85,322,860
Ensembl chr 1:85,312,528...85,317,968
JBrowse link
G Gmppa GDP-mannose pyrophosphorylase A increases expression EXP Glafenine results in increased expression of GMPPA mRNA CTD PMID:24136188 NCBI chr 9:82,632,267...82,639,811
Ensembl chr 9:82,632,230...82,639,821
JBrowse link
G Gmppb GDP-mannose pyrophosphorylase B increases expression EXP Glafenine results in increased expression of GMPPB mRNA CTD PMID:24136188 NCBI chr 8:116,826,251...116,856,159
Ensembl chr 8:116,826,680...116,856,159
JBrowse link
G Gnai2 G protein subunit alpha i2 increases expression EXP Glafenine results in increased expression of GNAI2 mRNA CTD PMID:24136188 NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
JBrowse link
G Gnat1 G protein subunit alpha transducin 1 increases expression EXP Glafenine results in increased expression of GNAT1 mRNA CTD PMID:24136188 NCBI chr 8:116,433,302...116,438,038
Ensembl chr 8:116,433,302...116,438,038
JBrowse link
G Gnmt glycine N-methyltransferase decreases expression EXP Glafenine results in decreased expression of GNMT mRNA CTD PMID:24136188 NCBI chr 9:16,565,274...16,568,626
Ensembl chr 9:16,565,225...16,568,627